Country Name,Country Code,Indicator Name,Indicator Code,1960,1961,1962,1963,1964,1965,1966,1967,1968,1969,1970,1971,1972,1973,1974,1975,1976,1977,1978,1979,1980,1981,1982,1983,1984,1985,1986,1987,1988,1989,1990,1991,1992,1993,1994,1995,1996,1997,1998,1999,2000,2001,2002,2003,2004,2005,2006,2007,2008,2009,2010,2011,2012,2013
Afghanistan,AFG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,19.85901,20.47498,21.090949,21.73429,22.37763,23.02097,23.66431,24.307655,24.94959,25.59153,26.23347,26.87541,27.517349,28.13148,28.74562,29.35975,29.97388,30.588014,31.2906,31.99319,32.69577,33.39835,34.10094,35.20177,36.30259,37.40342,38.50425,39.605079,40.83069,42.0563,43.28192,44.50753,45.733145,46.67563,47.61811,48.5606,49.50309,50.44557,51.07061,51.69564,52.32067,52.94571,53.570744,54.38072,55.1907,56.00068,56.81066,57.620638,58.38737,59.1541,59.92083,60.68756,,
Albania,ALB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,68.06444,69.86951,71.674605,71.99951,72.32442,72.64932,72.97423,73.299133,73.90025,74.50136,75.10247,75.70358,76.304709,76.86127,77.41782,77.97438,78.53094,79.087492,79.69184,80.29619,80.90054,81.50488,82.109235,82.7636,83.41798,84.07235,84.72672,85.381095,85.33508,85.28905,85.24303,85.19701,85.15098,85.40046,85.64993,85.89941,86.14888,86.398363,87.03221,87.66606,88.29991,88.93376,89.567596,89.64804,89.72849,89.80893,89.88937,89.969803,90.11726,90.26471,90.41216,90.55962,,
Algeria,DZA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,42.93762,43.53374,44.129873,44.70687,45.28387,45.86087,46.43787,47.014872,47.5493,48.08372,48.61814,49.15257,49.68699,50.66013,51.63327,52.60641,53.57956,54.552703,56.69613,58.83956,60.98299,63.12642,65.269844,66.56055,67.85125,69.14195,70.43266,71.723375,72.15381,72.58424,73.01468,73.44511,73.875549,74.19884,74.52214,74.84544,75.16873,75.492019,75.7825,76.07298,76.36346,76.65395,76.944435,77.16554,77.38665,77.60776,77.82887,78.049965,78.30243,78.55489,78.80736,79.05982,,
American Samoa,ASM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Andorra,ADO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Angola,AGO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,24.26719,24.76653,25.265868,25.78008,26.29429,26.8085,27.32271,27.836919,28.36443,28.89194,29.41944,29.94695,30.474459,30.96188,31.44931,31.93673,32.42416,32.911581,33.05817,33.20475,33.35133,33.49792,33.644499,33.97274,34.30098,34.62922,34.95746,35.285702,35.35332,35.42093,35.48855,35.55616,35.623777,35.96961,36.31544,36.66127,37.00711,37.352937,38.34142,39.32991,40.31839,41.30687,42.295358,42.92838,43.56141,44.19443,44.82745,45.460477,46.07137,46.68227,47.29317,47.90406,,
Antigua and Barbuda,ATG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,61.76661,62.42446,63.08232,63.70763,64.33295,64.95826,65.58357,66.20889,66.77731,67.34573,67.91415,68.48257,69.051,69.56815,70.0853,70.60246,71.11961,71.63675,72.1075,72.57825,73.049,73.51974,73.99048,74.4193,74.84811,75.27693,75.70575,76.13456,76.52505,76.91553,77.30602,77.69651,78.08699,78.44405,78.8011,79.15816,79.51521,79.87227,80.19791,80.52354,80.84918,81.17482,81.50045,81.79855,82.09666,82.39476,82.69286,82.99097,83.22131,83.45164,83.68197,83.9123,,
Arab World,ARB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,44.7054662697773,45.490835121602295,46.2784444924364,47.0987895616012,47.918648534607705,48.737606771931894,49.5548350728129,50.3707965738706,51.110955270007494,51.85450004096501,52.6022817263247,53.3572255372696,54.1162915182024,55.0335567163957,55.933576353239005,56.8098635176052,57.65893975161429,58.487282145298,59.5009735658123,60.527944423517,61.5811914941528,62.664922499863,63.7736089791695,64.7383413252496,65.70280477917089,66.6595588367138,67.6056968469908,68.54241683658451,69.1202270186452,69.6909999571148,70.2937168771408,70.8680331709863,71.32374679819121,71.8333221056963,72.33971617594659,72.91831974577941,73.4168738376583,73.9184644504423,74.23446753779609,74.5488166887241,74.860686978344,75.16924546011809,75.4751428675915,75.7453955436547,76.02018708924851,76.3001285811841,76.58651041025459,76.8772457159851,77.2150960729359,77.5440443200106,77.860681062761,78.16487494805641,,
Argentina,ARG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,71.88395,72.42568,72.967417,73.23286,73.49831,73.76376,74.02921,74.294664,74.69928,75.10389,75.5085,75.91311,76.317724,76.71934,77.12095,77.52256,77.92417,78.325783,78.74339,79.161,79.57861,79.99622,80.413832,80.625,80.83617,81.04733,81.2585,81.469666,81.75542,82.04117,82.32692,82.61267,82.898414,83.10087,83.30332,83.50578,83.70823,83.910701,84.13385,84.357,84.58015,84.80331,85.026453,85.26556,85.50468,85.74379,85.9829,86.222025,86.3878,86.55358,86.71936,86.88514,,
Armenia,ARM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,73.38272,74.08247,74.782235,75.3745,75.96676,76.55902,77.15128,77.743557,78.13486,78.52616,78.91747,79.30877,79.700074,79.66595,79.63184,79.59772,79.5636,79.529472,79.58985,79.65023,79.71061,79.77099,79.831382,78.84833,77.86528,76.88223,75.89919,74.916127,75.27981,75.64349,76.00718,76.37086,76.734548,77.28851,77.84248,78.39644,78.9504,79.504376,80.24513,80.98589,81.72664,82.46739,83.208158,83.56261,83.91705,84.2715,84.62595,84.980408,85.12057,85.26074,85.40091,85.54108,,
Aruba,ABW,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,69.91539,70.81051,71.705636,72.28394,72.86224,73.44054,74.01884,74.597137,75.50426,76.41138,77.3185,78.22562,79.132732,79.70136,80.27,80.83863,81.40726,81.975892,82.26398,82.55206,82.84015,83.12823,83.416329,83.59713,83.77793,83.95873,84.13953,84.320345,84.37944,84.43854,84.49763,84.55673,84.615829,84.67433,84.73283,84.79134,84.84984,84.908354,84.96352,85.01869,85.07386,85.12903,85.184202,85.3833,85.5824,85.78149,85.98059,86.179688,86.35745,86.53522,86.71298,86.89075,,
Australia,AUS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,80.4994,80.66163,80.823865,80.83707,80.85027,80.86348,80.87669,80.889888,81.10825,81.32662,81.54499,81.76336,81.981719,82.44603,82.91034,83.37465,83.83896,84.303254,84.75827,85.21329,85.6683,86.12332,86.57835,86.80354,87.02872,87.25391,87.4791,87.704296,88.01816,88.33202,88.64589,88.95975,89.273621,89.51331,89.75299,89.99268,90.23236,90.472053,90.70067,90.92928,91.1579,91.38651,91.61514,91.78197,91.9488,92.11563,92.28246,92.449285,92.56274,92.67619,92.78963,92.90308,,
Austria,AUT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.8393,79.34816,79.857027,80.06551,80.27399,80.48248,80.69096,80.899448,81.13302,81.36659,81.60017,81.83374,82.067306,82.41718,82.76704,83.11691,83.46678,83.816646,84.08829,84.35994,84.63158,84.90323,85.174877,85.58059,85.98631,86.39202,86.79774,87.203454,87.43357,87.66368,87.89379,88.1239,88.354021,88.61263,88.87124,89.12984,89.38845,89.647068,89.84802,90.04898,90.24994,90.4509,90.651849,90.84281,91.03378,91.22474,91.4157,91.606673,91.74332,91.87996,92.0166,92.15324,,
Azerbaijan,AZE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,72.45952,73.00471,73.549919,74.04637,74.54282,75.03928,75.53573,76.032179,76.38803,76.74388,77.09973,77.45558,77.811433,77.74113,77.67084,77.60054,77.53024,77.459941,77.43325,77.40656,77.37988,77.35319,77.326484,77.60369,77.8809,78.1581,78.43531,78.71251,77.81142,76.91032,76.00922,75.10812,74.207026,74.48663,74.76622,75.04581,75.32541,75.605016,75.83261,76.0602,76.2878,76.51539,76.742973,77.59373,78.44448,79.29523,80.14599,80.99676,81.17806,81.35937,81.54067,81.72198,,
"Bahamas, The",BHS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,65.36028,65.92454,66.488816,67.00098,67.51314,68.0253,68.53746,69.049604,69.51469,69.97978,70.44487,70.90996,71.375059,71.79783,72.2206,72.64338,73.06615,73.488918,73.87376,74.2586,74.64344,75.02828,75.413114,75.76402,76.11491,76.46581,76.81671,77.16761,77.42972,77.69183,77.95393,78.21604,78.478155,78.61011,78.74206,78.87401,79.00596,79.13791,79.42025,79.70259,79.98493,80.26727,80.549622,80.73439,80.91916,81.10393,81.2887,81.473449,81.73563,81.9978,82.25998,82.52216,,
Bahrain,BHR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,54.91107,56.60315,58.295213,59.74964,61.20406,62.65849,64.11292,65.567344,66.68484,67.80233,68.91982,70.03732,71.154817,71.97186,72.78891,73.60596,74.423,75.240045,75.8378,76.43555,77.03331,77.63107,78.228813,78.65173,79.07465,79.49757,79.92049,80.343397,80.68977,81.03616,81.38254,81.72892,82.07529,82.45065,82.826,83.20135,83.5767,83.952059,84.28584,84.61963,84.95341,85.2872,85.620996,85.91809,86.21519,86.51228,86.80938,87.106469,87.29212,87.47778,87.66343,87.84908,,
Bangladesh,BGD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,41.2325,41.87548,42.518462,43.06143,43.60439,44.14736,44.69032,45.233295,44.54015,43.847,43.15386,42.46071,41.767572,43.51511,45.26264,47.01018,48.75771,50.505246,51.2693,52.03336,52.79742,53.56147,54.325531,55.10034,55.87514,56.64995,57.42476,58.199558,58.95671,59.71386,60.471,61.22815,61.985302,62.79525,63.6052,64.41515,65.2251,66.035045,66.77215,67.50925,68.24635,68.98344,69.720556,70.35318,70.9858,71.61842,72.25105,72.883671,73.54025,74.19682,74.8534,75.50998,,
Barbados,BRB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,63.29944,64.03507,64.770704,65.44144,66.11217,66.78291,67.45365,68.124386,68.73359,69.34279,69.95199,70.56119,71.170397,71.72208,72.27377,72.82546,73.37715,73.928836,74.42735,74.92587,75.42439,75.92291,76.421432,76.87122,77.321,77.77078,78.22057,78.670347,79.07574,79.48114,79.88654,80.29193,80.697343,81.06252,81.4277,81.79288,82.15807,82.523236,82.8521,83.18097,83.50983,83.8387,84.167565,84.46374,84.75991,85.05608,85.35226,85.648421,85.92025,86.19208,86.46391,86.73573,,
Belarus,BLR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.17501,76.97408,77.773154,78.24076,78.70837,79.17597,79.64358,80.111172,80.30422,80.49727,80.69032,80.88336,81.07641,81.13496,81.19352,81.25208,81.31063,81.369184,81.39325,81.41731,81.44138,81.46544,81.489506,81.78021,82.07092,82.36162,82.65232,82.94302,82.6157,82.28838,81.96107,81.63375,81.306425,80.83746,80.3685,79.89954,79.43057,78.961612,79.03534,79.10907,79.1828,79.25653,79.330246,79.78726,80.24428,80.70129,81.15831,81.615311,81.77797,81.94063,82.10329,82.26595,,
Belgium,BEL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,80.06043,80.42659,80.792733,80.93201,81.0713,81.21058,81.34986,81.489151,81.69396,81.89877,82.10358,82.3084,82.513197,82.81396,83.11473,83.4155,83.71626,84.017036,84.32215,84.62727,84.93238,85.2375,85.542617,85.86425,86.18588,86.50751,86.82915,87.150775,87.38964,87.6285,87.86736,88.10622,88.345085,88.50066,88.65623,88.8118,88.96737,89.122926,89.24637,89.36981,89.49326,89.6167,89.740129,89.86442,89.98871,90.113,90.23729,90.361582,90.50275,90.64393,90.7851,90.92628,,
Belize,BLZ,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,61.05959,61.9444,62.829216,63.72456,64.6199,65.51525,66.4106,67.305943,68.15725,69.00855,69.85986,70.71116,71.562459,72.33701,73.11157,73.88613,74.66069,75.435241,75.99689,76.55855,77.1202,77.68185,78.243497,78.64837,79.05324,79.45811,79.86298,80.267852,79.90218,79.5365,79.17082,78.80515,78.439486,78.25042,78.06136,77.87229,77.68323,77.494169,77.90269,78.31121,78.71973,79.12826,79.536777,79.71117,79.88557,80.05997,80.23438,80.408766,80.77986,81.15096,81.52205,81.89314,,
Benin,BEN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,28.43876,29.09505,29.751336,30.67059,31.58984,32.50909,33.42835,34.347598,35.58913,36.83065,38.07218,39.31371,40.55524,41.5175,42.47976,43.44201,44.40427,45.366528,45.99034,46.61415,47.23797,47.86178,48.485589,49.47958,50.47358,51.46758,52.46157,53.455567,54.1926,54.92964,55.66667,56.40371,57.140743,56.90131,56.66187,56.42243,56.18299,55.943551,56.08911,56.23466,56.38022,56.52578,56.671341,57.26707,57.86281,58.45854,59.05428,59.650008,59.97597,60.30193,60.62788,60.95384,,
Bermuda,BMU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Bhutan,BTN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,19.86558,20.15674,20.447897,20.76251,21.07712,21.39173,21.70634,22.020951,22.76583,23.51071,24.25559,25.00047,25.745343,26.70276,27.66019,28.61761,29.57503,30.532453,31.46257,32.39269,33.32281,34.25293,35.183055,36.15002,37.11699,38.08396,39.05093,40.017907,41.15844,42.29897,43.43951,44.58004,45.720566,46.91458,48.1086,49.30261,50.49663,51.690648,52.86439,54.03814,55.21188,56.38562,57.559369,58.70562,59.85186,60.99811,62.14436,63.29061,64.06945,64.84829,65.62713,66.40597,,
Bolivia,BOL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,40.1684,40.5662,40.964,41.3822,41.8004,42.2186,42.6368,43.055,43.4972,43.9394,44.3816,44.8238,45.266,46.0958,46.9256,47.7554,48.5852,49.415,50.4098,51.4046,52.3994,53.3942,54.389,55.2348,56.0806,56.9264,57.77219,58.618,59.3486,60.0792,60.8098,61.54039,62.271,62.921,63.571,64.221,64.871,65.521,66.0454,66.5698,67.0942,67.6186,68.143,68.5974,69.0518,69.5062,69.96059,70.415,70.90598,71.39697,71.88795,72.37893,,
Bosnia and Herzegovina,BIH,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,64.46708,65.45422,66.441368,67.28874,68.13612,68.98349,69.83086,70.67822,71.52314,72.36806,73.21297,74.05789,74.902811,75.66021,76.41761,77.17501,77.93241,78.6898,79.00636,79.32291,79.63946,79.95601,80.272572,80.55049,80.82841,81.10634,81.38426,81.662178,81.42332,81.18447,80.94562,80.70676,80.467927,81.254,82.04007,82.82614,83.61221,84.398275,84.79372,85.18916,85.58459,85.98003,86.375464,86.5391,86.70274,86.86637,87.03001,87.193657,87.36896,87.54426,87.71956,87.89486,,
Botswana,BWA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,47.08463,47.6002,48.115769,48.61616,49.11655,49.61694,50.11733,50.617724,51.55661,52.4955,53.43439,54.37328,55.312162,56.33549,57.35882,58.38214,59.40547,60.428802,61.2256,62.0224,62.8192,63.616,64.412791,64.95438,65.49596,66.03755,66.57914,67.120712,66.10448,65.08826,64.07203,63.0558,62.039572,58.66825,55.29694,51.92562,48.55431,45.182992,42.28001,39.37704,36.47406,33.57108,30.668098,29.26787,27.86765,26.46742,25.06719,23.666963,23.39629,23.12562,22.85494,22.58427,,
Brazil,BRA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,53.2412,54.0346,54.828,55.5348,56.2416,56.9484,57.6552,58.362,58.9738,59.5856,60.1974,60.8092,61.421,61.9462,62.4714,62.9966,63.5218,64.047,65.0212,65.9954,66.9696,67.94379,68.918,69.5254,70.1328,70.7402,71.3476,71.955,72.4884,73.0218,73.55521,74.08861,74.622,75.0192,75.4164,75.81361,76.21081,76.608,76.9754,77.3428,77.71021,78.07761,78.445,78.7866,79.1282,79.4698,79.81139,80.153,80.4821,80.8112,81.1403,81.46941,,
Brunei Darussalam,BRN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,64.86153,65.72277,66.584011,67.38758,68.19115,68.99473,69.7983,70.601876,71.31175,72.02163,72.73151,73.44138,74.151255,74.77608,75.40091,76.02573,76.65056,77.275391,77.82403,78.37267,78.9213,79.46994,80.018568,80.49959,80.98061,81.46162,81.94264,82.423667,82.84508,83.26649,83.6879,84.10931,84.530733,84.89984,85.26895,85.63806,86.00717,86.37627,86.69962,87.02296,87.34631,87.66966,87.993001,88.27638,88.55977,88.84315,89.12654,89.409921,89.66616,89.9224,90.17864,90.43488,,
Bulgaria,BGR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.94027,77.99984,79.059409,79.46078,79.86217,80.26355,80.66493,81.066307,81.22041,81.3745,81.5286,81.6827,81.836785,81.9131,81.98941,82.06572,82.14203,82.218347,82.31971,82.42107,82.52244,82.6238,82.725176,82.835,82.94482,83.05465,83.16447,83.274307,83.25427,83.23424,83.2142,83.19417,83.174146,83.11184,83.04953,82.98722,82.92491,82.862595,83.12928,83.39597,83.66265,83.92934,84.196015,84.41301,84.63,84.847,85.064,85.280985,85.42404,85.56709,85.71014,85.8532,,
Burkina Faso,BFA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,26.68411,27.29998,27.915862,28.55505,29.19423,29.83341,30.4726,31.111778,31.77303,32.43428,33.09552,33.75677,34.418023,35.34854,36.27906,37.20958,38.1401,39.070617,40.65471,42.2388,43.82289,45.40698,46.991076,47.17993,47.36879,47.55764,47.74649,47.93535,47.78803,47.64071,47.49339,47.34607,47.198756,47.35183,47.50491,47.65799,47.81106,47.96414,48.26888,48.57362,48.87835,49.18309,49.487827,50.04824,50.60866,51.16908,51.7295,52.289918,52.91729,53.54467,54.17205,54.79942,,
Burundi,BDI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,35.08697,35.50018,35.913381,36.32971,36.74604,37.16238,37.57871,37.995033,38.19214,38.38925,38.58636,38.78347,38.980585,39.5968,40.21302,40.82923,41.44545,42.061663,42.54296,43.02425,43.50555,43.98685,44.468137,44.5996,44.73107,44.86253,44.994,45.125467,44.17739,43.22932,42.28124,41.33317,40.385095,40.32787,40.27064,40.21341,40.15618,40.09895,40.37863,40.65831,40.93798,41.21766,41.497338,42.51776,43.53817,44.55859,45.57901,46.599427,47.73053,48.86163,49.99274,51.12384,,
Cambodia,KHM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,31.33674,31.59103,31.845315,32.1646,32.48388,32.80316,33.12244,33.441721,32.72033,31.99894,31.27755,30.55616,29.834772,25.1711,20.50743,15.84376,11.1801,6.516428,13.94402,21.37161,28.7992,36.22679,43.654378,44.91676,46.17915,47.44154,48.70392,49.966309,50.96481,51.9633,52.9618,53.9603,54.958794,56.00129,57.04379,58.08628,59.12878,60.171269,61.30978,62.44829,63.5868,64.72531,65.863825,67.02727,68.19071,69.35416,70.5176,71.681039,72.2757,72.87037,73.46503,74.0597,,
Cameroon,CMR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,35.25309,35.8573,36.461502,37.06264,37.66378,38.26492,38.86606,39.467196,40.23882,41.01045,41.78208,42.55371,43.325335,44.0627,44.80007,45.53743,46.2748,47.012163,47.61379,48.21541,48.81704,49.41866,50.020287,50.33249,50.64468,50.95687,51.26907,51.58127,51.53824,51.49522,51.45219,51.40916,51.366133,50.69229,50.01845,49.3446,48.67076,47.996922,47.30574,46.61456,45.92338,45.2322,44.541014,44.93424,45.32746,45.72068,46.11391,46.507129,47.21755,47.92798,48.6384,49.34883,,
Canada,CAN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,80.37613,80.75594,81.135751,81.35525,81.57475,81.79424,82.01374,82.233223,82.45927,82.68531,82.91135,83.1374,83.363451,83.66286,83.96227,84.26167,84.56108,84.860487,85.20528,85.55009,85.89489,86.23969,86.58449,86.8094,87.03432,87.25923,87.48415,87.709062,87.89945,88.08984,88.28024,88.47063,88.661007,88.8168,88.97258,89.12836,89.28415,89.439942,89.59855,89.75716,89.91576,90.07437,90.232983,90.34111,90.44924,90.55737,90.6655,90.773621,90.89345,91.01328,91.1331,91.25293,,
Cape Verde,CPV,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,43.85155,44.06422,44.276895,44.59438,44.91187,45.22936,45.54685,45.864336,46.82444,47.78453,48.74463,49.70473,50.66483,51.9138,53.16276,54.41173,55.66069,56.909662,58.19784,59.48602,60.77419,62.06237,63.350546,64.73061,66.11068,67.49075,68.87081,70.250877,71.14796,72.04506,72.94215,73.83925,74.736332,75.57796,76.41958,77.2612,78.10282,78.944453,79.7421,80.53976,81.33741,82.13506,82.93271,83.54469,84.15668,84.76866,85.38065,85.992638,86.43552,86.8784,87.32127,87.76415,,
Caribbean small states,CSS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,65.3123319586899,66.0925068499088,66.87649256071589,67.3387366240556,67.79568708587439,68.2437932678631,68.68237022266389,69.1130563766467,69.5163712475135,69.9291550818264,70.3573267792636,70.80173277907329,71.2599441723522,71.6282697199137,71.99790113177241,72.36414381915279,72.7262844432009,73.0849191956774,73.3291315129682,73.5782498900326,73.8349809455212,74.09583017590509,74.3657686983348,74.54658132879241,74.7260013986232,74.899251676321,75.0674387746814,75.2293498931065,75.32242005910541,75.4203843555423,75.51501413883909,75.60874621563029,75.7016108411601,75.82529024927571,75.947746042997,76.06873955142291,76.19073177530271,76.3090862883646,76.5128772130934,76.71651436825721,76.9214183531266,77.1282222847268,77.3360681994707,77.6127251909445,77.8913306675033,78.17115700283941,78.45249681386929,78.735085794814,79.0106335015163,79.28470336862641,79.5567153579045,79.8272946199787,,
Cayman Islands,CYM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Central African Republic,CAF,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,28.91182,29.47029,30.028752,30.74657,31.46438,32.18219,32.90001,33.617823,34.70152,35.78521,36.86891,37.9526,39.036297,40.11706,41.19783,42.27859,43.35936,44.44012,44.91801,45.3959,45.87379,46.35168,46.829579,46.21429,45.599,44.98372,44.36843,43.753132,42.71613,41.67913,40.64214,39.60514,38.568147,37.96403,37.35991,36.75579,36.15167,35.547551,35.46904,35.39054,35.31203,35.23352,35.155018,35.95034,36.74567,37.54099,38.33631,39.131639,40.2855,41.43937,42.59323,43.74709,,
Chad,TCD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,31.41272,31.64278,31.872845,32.12154,32.37024,32.61893,32.86763,33.116316,33.74037,34.36443,34.98848,35.61253,36.236585,36.55406,36.87153,37.189,37.50647,37.823941,38.21701,38.61007,39.00314,39.39621,39.789269,39.96734,40.14541,40.32348,40.50155,40.679613,40.5401,40.4006,40.26109,40.12158,39.98207,39.82519,39.66831,39.51143,39.35455,39.197667,39.10574,39.0138,38.92187,38.82993,38.738005,39.3362,39.9344,40.5326,41.1308,41.729003,42.45399,43.17899,43.90398,44.62897,,
Channel Islands,CHI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,80.85095,81.06788,81.284817,81.55314,81.82146,82.08979,82.35812,82.62643,82.78135,82.93627,83.09119,83.24612,83.401041,83.62043,83.83982,84.05921,84.2786,84.49799,84.80809,85.11819,85.4283,85.7384,86.048496,86.25858,86.46867,86.67875,86.88883,87.098928,87.34702,87.59511,87.8432,88.09129,88.339377,88.50536,88.67135,88.83733,89.00332,89.169293,89.39616,89.62304,89.84991,90.07679,90.303665,90.52988,90.7561,90.98232,91.20854,91.434762,91.55052,91.66628,91.78204,91.8978,,
Chile,CHL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,58.377,59.02,59.663,60.3976,61.1322,61.8668,62.6014,63.336,64.2718,65.2076,66.14339,67.07919,68.015,69.2478,70.48061,71.71341,72.94621,74.179,75.357,76.535,77.71301,78.89101,80.069,80.5524,81.0358,81.5192,82.00259,82.486,82.8796,83.2732,83.6668,84.0604,84.454,84.8046,85.1552,85.50581,85.85641,86.207,86.6718,87.1366,87.60139,88.06619,88.531,88.6922,88.8534,89.0146,89.1758,89.337,89.52041,89.70382,89.88723,90.07064,,
China,CHN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,37.87365,38.11117,38.348698,42.44623,46.54376,50.64129,54.73882,58.836342,60.70501,62.57367,64.44233,66.31099,68.179656,68.74736,69.31507,69.88278,70.45049,71.018193,71.51775,72.01732,72.51688,73.01645,73.516006,73.95838,74.40076,74.84313,75.28551,75.727891,76.12215,76.51642,76.91068,77.30495,77.699223,78.05278,78.40634,78.7599,79.11346,79.467011,80.06745,80.66789,81.26833,81.86877,82.469222,82.79569,83.12216,83.44863,83.7751,84.101571,84.45311,84.80465,85.15619,85.50773,,
Colombia,COL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,57.5774,58.30721,59.037,59.5974,60.1578,60.7182,61.27859,61.839,62.3618,62.8846,63.4074,63.9302,64.453,65.152,65.851,66.55,67.24899,67.948,69.2264,70.5048,71.7832,73.06159,74.34,74.7844,75.2288,75.67319,76.11759,76.562,76.9514,77.3408,77.73019,78.11959,78.509,78.8294,79.1498,79.47019,79.79059,80.111,80.4252,80.7394,81.0536,81.36781,81.682,82.0008,82.3196,82.6384,82.95721,83.276,83.50904,83.74208,83.97512,84.20816,,
Comoros,COM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,36.54888,37.10593,37.662979,38.23094,38.7989,39.36686,39.93481,40.502778,41.35822,42.21367,43.06911,43.92456,44.780007,45.34966,45.91931,46.48896,47.05862,47.628275,48.21769,48.8071,49.39651,49.98593,50.575346,51.17889,51.78244,52.38599,52.98953,53.593084,53.89978,54.20647,54.51316,54.81985,55.12654,55.43638,55.74622,56.05605,56.36589,56.675734,56.98915,57.30258,57.616,57.92942,58.242847,58.55793,58.873,59.18808,59.50316,59.81824,60.1997,60.58116,60.96262,61.34407,,
"Congo, Dem. Rep.",ZAR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,34.49022,34.78379,35.077369,35.45158,35.82579,36.20001,36.57422,36.948431,37.44565,37.94287,38.44009,38.93731,39.434518,39.67718,39.91985,40.16251,40.40517,40.647831,40.92166,41.19548,41.46931,41.74314,42.016959,42.18056,42.34416,42.50776,42.67136,42.834971,42.90638,42.9778,43.04921,43.12063,43.192041,42.71892,42.2458,41.77269,41.29957,40.826447,41.29956,41.77268,42.2458,42.71892,43.192041,43.49552,43.799,44.10247,44.40595,44.709423,45.17513,45.64083,46.10654,46.57225,,
"Congo, Rep.",COG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,44.92852,45.91323,46.897946,47.61357,48.3292,49.04483,49.76046,50.476086,50.91426,51.35244,51.79061,52.22879,52.666965,53.05881,53.45066,53.8425,54.23435,54.626202,54.9769,55.3276,55.6783,56.02899,56.379694,56.1451,55.91051,55.67593,55.44134,55.20675,54.00032,52.7939,51.58747,50.38105,49.174624,48.49016,47.80569,47.12123,46.43677,45.752298,45.89622,46.04015,46.18407,46.328,46.47193,47.60443,48.73693,49.86943,51.00193,52.134421,53.19191,54.24939,55.30688,56.36437,,
Costa Rica,CRI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,64.777,65.763,66.749,67.704,68.659,69.61401,70.56901,71.524,72.4034,73.2828,74.1622,75.0416,75.921,76.6994,77.4778,78.2562,79.03459,79.813,80.536,81.259,81.982,82.705,83.428,83.7818,84.1356,84.4894,84.84319,85.197,85.4338,85.6706,85.9074,86.1442,86.381,86.6082,86.8354,87.06261,87.28981,87.517,87.7054,87.8938,88.0822,88.2706,88.459,88.6074,88.7558,88.9042,89.0526,89.201,89.34895,89.49689,89.64484,89.79279,,
Cote d'Ivoire,CIV,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,30.17458,30.96319,31.751808,32.41133,33.07086,33.73039,34.38992,35.049449,36.37452,37.69959,39.02466,40.34973,41.674804,42.65588,43.63697,44.61805,45.59913,46.580211,47.28701,47.99381,48.70061,49.40741,50.114208,50.4624,50.8106,51.1588,51.507,51.855189,51.25625,50.65731,50.05837,49.45943,48.860494,46.73837,44.61625,42.49412,40.372,38.249869,37.78215,37.31442,36.8467,36.37897,35.911256,36.68781,37.46437,38.24093,39.01749,39.794042,40.3379,40.88176,41.42561,41.96947,,
Croatia,HRV,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,71.75953,72.50662,73.253723,73.93552,74.61732,75.29913,75.98093,76.662739,77.25636,77.84998,78.4436,79.03722,79.630853,80.12543,80.62,81.11458,81.60915,82.103721,82.22578,82.34783,82.46989,82.59194,82.713981,82.99751,83.28104,83.56458,83.84811,84.131626,84.435,84.73837,85.04173,85.3451,85.648469,86.07794,86.50742,86.93689,87.36636,87.79583,87.88023,87.96464,88.04904,88.13345,88.217835,88.46558,88.71333,88.96108,89.20883,89.456579,89.60207,89.74755,89.89304,90.03852,,
Cuba,CUB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,69.64445,70.5042,71.363963,72.24652,73.12908,74.01164,74.8942,75.776761,76.38342,76.99007,77.59673,78.20339,78.81004,79.18513,79.56022,79.93531,80.3104,80.685488,80.98093,81.27637,81.57181,81.86725,82.162682,82.30384,82.445,82.58616,82.72732,82.868493,82.89055,82.91261,82.93466,82.95672,82.97878,83.41634,83.85389,84.29144,84.729,85.16656,85.40635,85.64614,85.88593,86.12572,86.365513,86.68209,86.99866,87.31524,87.63181,87.948397,88.09327,88.23814,88.38302,88.52789,,
Curacao,CUW,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,68.35949,69.251,70.14251,70.73424,71.32597,71.91769,72.50942,73.10116,73.88125,74.66134,75.44143,76.22152,77.0016,77.94663,78.89166,79.83669,80.78172,81.72677,82.14237,82.55798,82.97358,83.38918,83.80478,84.03495,84.26512,84.49529,84.72546,84.95563,85.02461,85.09359,85.16257,85.23154,85.30053,85.3219,85.34326,85.36462,85.38599,85.40736,85.55903,85.71069,85.86236,86.01402,86.1657,86.36745,86.56921,86.77097,86.97273,87.17449,87.32459,87.4747,87.62481,87.77492,,
Cyprus,CYP,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,80.13883,80.61176,81.08468,81.49064,81.89659,82.30254,82.7085,83.11446,83.46458,83.8147,84.16482,84.51494,84.86506,85.16806,85.47106,85.77406,86.07706,86.38008,86.64417,86.90826,87.17236,87.43645,87.70055,87.93136,88.16216,88.39297,88.62377,88.85458,89.05803,89.26148,89.46494,89.66839,89.87183,90.05136,90.23089,90.41042,90.58994,90.76947,90.92933,91.08919,91.24905,91.40891,91.56875,91.71109,91.85343,91.99577,92.13811,92.28045,92.38857,92.49667,92.60478,92.71289,,
Czech Republic,CZE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,80.35705,80.76831,81.179579,81.20866,81.23773,81.26681,81.29588,81.324971,81.30112,81.27728,81.25343,81.22958,81.205742,81.43138,81.65702,81.88266,82.1083,82.333928,82.31357,82.29321,82.27284,82.25248,82.232121,82.46861,82.7051,82.94159,83.17808,83.414579,83.65746,83.90034,84.14323,84.38611,84.628993,85.02334,85.41769,85.81203,86.20638,86.600727,86.88619,87.17165,87.45712,87.74258,88.02805,88.2621,88.49615,88.73019,88.96424,89.198294,89.33582,89.47334,89.61086,89.74837,,
Denmark,DNK,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,81.93832,82.18925,82.440184,82.53632,82.63247,82.72861,82.82476,82.9209,83.01295,83.10501,83.19707,83.28912,83.381187,83.51674,83.65229,83.78784,83.92339,84.058948,84.00397,83.949,83.89402,83.83904,83.784077,83.75779,83.73151,83.70522,83.67894,83.652653,83.79498,83.93732,84.07965,84.22198,84.364306,84.61235,84.8604,85.10844,85.35649,85.604541,86.00376,86.40298,86.80221,87.20143,87.600641,87.8664,88.13216,88.39793,88.66369,88.92944,89.05762,89.18579,89.31396,89.44214,,
Djibouti,DJI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,38.69596,39.31289,39.929812,40.53334,41.13688,41.74041,42.34395,42.947482,43.99345,45.03941,46.08537,47.13134,48.177299,48.65397,49.13064,49.60731,50.08398,50.560653,51.18185,51.80305,52.42424,53.04544,53.666634,54.08867,54.5107,54.93274,55.35477,55.776802,56.02808,56.27937,56.53065,56.78193,57.033214,56.84296,56.65271,56.46246,56.27221,56.081963,55.96504,55.84812,55.7312,55.61428,55.497352,56.13341,56.76946,57.40552,58.04157,58.677626,59.5746,60.47158,61.36855,62.26553,,
Dominica,DMA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Dominican Republic,DOM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,51.8898,52.9994,54.109,55.1082,56.1074,57.1066,58.1058,59.105,59.8134,60.5218,61.2302,61.9386,62.647,63.0474,63.4478,63.8482,64.2486,64.649,65.129,65.609,66.089,66.56901,67.049,67.7668,68.4846,69.20239,69.92019,70.638,71.2708,71.90359,72.53639,73.16919,73.802,74.1834,74.5648,74.94621,75.32761,75.709,76.0724,76.43581,76.79921,77.16261,77.526,77.8274,78.1288,78.4302,78.7316,79.033,79.30115,79.56929,79.83743,80.10558,,
East Asia & Pacific (all income levels),EAS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,44.9737604366747,45.6817728286261,46.2611316738998,49.1172049900685,51.9771147380564,54.8320544716487,57.672095354621106,60.51939187283399,61.8838106454127,63.2839697762502,64.66322066370111,66.04530634047751,67.4218639694149,68.0173885675057,68.6355172294034,69.2520309226766,69.859797459257,70.477820593773,71.0369910566488,71.595157147184,72.1483882419182,72.6994568045435,73.2488689938669,73.73207111671579,74.2165315661966,74.70408807839941,75.1958873268645,75.6898890733098,76.096014904905,76.502766704553,76.9077687643286,77.3121925846128,77.7151840885604,78.0250262082666,78.3370412011763,78.6517324386512,78.966515710504,79.2805317806703,79.7796103694071,80.2803665236265,80.784979796062,81.29409648734791,81.80609650152691,82.1282822069377,82.4508752199285,82.773225288653,83.09614564812979,83.4193227146458,83.73050855873991,84.0389044736589,84.3452594502198,84.65208241341841,,
East Asia & Pacific (developing only),EAP,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,40.315143169906605,40.7802945915073,41.2151990421491,44.442164598077795,47.676562800171496,50.914897395995595,54.1586853054785,57.4082217390401,58.9419138389411,60.4770662587228,62.0105532448288,63.539262107790606,65.0563973017553,65.6881568287508,66.3234013130728,66.96411091858229,67.61309216002181,68.268935909601,68.8788529189129,69.4861479482018,70.0870220463247,70.68346791660859,71.2798970191325,71.805583921532,72.3277098221674,72.84965594237221,73.3729753897451,73.897298962473,74.33892830240829,74.7782933805492,75.21481098779721,75.6494125037073,76.0821453230181,76.4188928910498,76.7575530889224,77.09854162542109,77.4417575027434,77.7873976703538,78.340204479273,78.8951423513477,79.45280196158191,80.01399992986009,80.57797628815459,80.93733697060641,81.29568796230471,81.65158711994529,82.00424396935449,82.3540967095676,82.6924324242338,83.0277530797404,83.3600632761347,83.6893962744749,,
East Asia and the Pacific (IFC classification),CEA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ecuador,ECU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,52.479,53.557,54.635,55.2394,55.8438,56.4482,57.0526,57.657,58.2924,58.9278,59.5632,60.1986,60.834,61.6764,62.5188,63.3612,64.2036,65.046,66.087,67.128,68.169,69.21,70.251,70.9916,71.7322,72.4728,73.2134,73.954,74.5956,75.2372,75.8788,76.5204,77.162,77.7622,78.3624,78.96259,79.56279,80.163,80.66094,81.15888,81.65682,82.15476,82.6527,82.85736,83.06202,83.26668,83.47134,83.676,83.97066,84.26531,84.55997,84.85462,,
"Egypt, Arab Rep.",EGY,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,50.99754,51.74912,52.500697,53.12692,53.75315,54.37937,55.0056,55.631822,56.0192,56.40657,56.79395,57.18132,57.568699,58.48435,59.4,60.31565,61.2313,62.146951,62.9062,63.66545,64.4247,65.18394,65.943199,66.80105,67.65891,68.51676,69.37462,70.232464,70.68858,71.1447,71.60081,72.05693,72.51306,73.09664,73.68022,74.2638,74.84738,75.430973,75.68366,75.93636,76.18905,76.44174,76.694424,76.91093,77.12743,77.34393,77.56042,77.776924,78.17965,78.58237,78.9851,79.38783,,
El Salvador,SLV,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,50.3792,51.6496,52.92,53.8764,54.8328,55.7892,56.74561,57.702,58.3372,58.9724,59.6076,60.2428,60.878,61.1878,61.4976,61.8074,62.1172,62.427,62.7054,62.9838,63.2622,63.5406,63.819,65.2214,66.62379,68.02619,69.42859,70.831,71.8912,72.9514,74.0116,75.07181,76.132,76.388,76.644,76.89999,77.15599,77.412,77.6982,77.9844,78.2706,78.5568,78.843,79.121,79.399,79.677,79.955,80.233,80.50197,80.77094,81.03992,81.30889,,
Equatorial Guinea,GNQ,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,29.01118,29.40216,29.79315,30.19395,30.59474,30.99554,31.39634,31.797134,32.2063,32.61546,33.02463,33.43379,33.842956,34.2543,34.66565,35.077,35.48834,35.899693,36.43846,36.97723,37.516,38.05477,38.593539,39.06234,39.53114,39.99994,40.46874,40.937539,41.34855,41.75956,42.17056,42.58157,42.992583,43.0538,43.11502,43.17625,43.23747,43.298688,43.22185,43.14501,43.06817,42.99133,42.914492,43.53386,44.15322,44.77258,45.39194,46.011301,46.8896,47.7679,48.6462,49.5245,,
Eritrea,ERI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,24.77999,25.02375,25.267513,25.598,25.92849,26.25897,26.58946,26.919949,27.23564,27.55132,27.86701,28.18269,28.498379,28.72729,28.9562,29.18512,29.41403,29.642938,29.86911,30.09529,30.32146,30.54763,30.773808,31.60272,32.43163,33.26054,34.08945,34.918368,36.12881,37.33926,38.54971,39.76016,40.970611,42.452,43.9334,45.41479,46.89618,48.377568,49.33512,50.29267,51.25022,52.20777,53.165313,54.10622,55.04712,55.98802,56.92892,57.869826,58.79981,59.72979,60.65977,61.58975,,
Estonia,EST,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,79.08266,79.80717,80.531679,80.83691,81.14215,81.44739,81.75262,82.057869,82.08096,82.10406,82.12715,82.15025,82.17333,82.04764,81.92194,81.79625,81.67056,81.54486,81.43859,81.33232,81.22605,81.11978,81.013524,81.18861,81.3637,81.53879,81.71387,81.888958,81.50169,81.11442,80.72715,80.33988,79.952601,80.18978,80.42696,80.66413,80.90131,81.138492,81.57714,82.01579,82.45443,82.89307,83.331722,83.90002,84.46833,85.03664,85.60494,86.17325,86.31045,86.44765,86.58485,86.72205,,
Ethiopia,ETH,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,31.35982,32.29354,33.227254,33.78913,34.35101,34.91288,35.47475,36.036634,36.41385,36.79106,37.16827,37.54549,37.922702,38.12888,38.33505,38.54122,38.74739,38.953568,38.72867,38.50378,38.27888,38.05399,37.829095,38.49696,39.16481,39.83267,40.50053,41.168394,41.52953,41.89066,42.2518,42.61293,42.97407,43.40037,43.82667,44.25297,44.67927,45.105573,45.74283,46.38009,47.01735,47.65461,48.291869,50.11733,51.9428,53.76826,55.59373,57.419194,59.1255,60.8318,62.5381,64.24441,,
Euro area,EMU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,79.11284912330301,79.5879757628612,80.0649446022336,80.35567786102759,80.64723111521491,80.9392759943853,81.23087056050659,81.52165285475591,81.81853299823301,82.1153562725377,82.41297034391751,82.7099351240887,83.00505678900251,83.37445039617829,83.7432212552783,84.1108817224412,84.479802052017,84.8502413248646,85.19048099419129,85.5293068094152,85.8667825931914,86.20427951828621,86.5415031175906,86.8144184224536,87.0882452991457,87.3628096961471,87.6374650630835,87.9124966912501,88.1217324601388,88.32988180473879,88.5371390486787,88.7443733845447,88.95206789028299,89.16847631935309,89.38472191025869,89.6004434011191,89.8156405261829,90.0305775286553,90.2216546071767,90.4125947980215,90.6039085876927,90.79549296921742,90.98789355786909,91.161602972772,91.3363250677018,91.5111010251024,91.68615107758659,91.86220763870709,91.9954761052656,92.12647202657429,92.2557591848377,92.3841114195406,,
Europe & Central Asia (all income levels),ECS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.3574872124956,76.981726368189,77.6091851117184,77.9245704183786,78.2378225914265,78.54795640083441,78.8530788372469,79.1544271235188,79.3590525154443,79.56487781438379,79.77199467405259,79.9809576489981,80.1929618809103,80.339289994439,80.486833915787,80.6358127407253,80.78728759158409,80.942578982788,81.1279068944195,81.3163238303505,81.5079915693615,81.703133824094,81.8998897912067,82.1816069838059,82.4615026699676,82.7407202343113,83.0199583317246,83.2985622117391,83.2677137250989,83.2400076377159,83.2177262406319,83.19773991864409,83.18454304334821,83.2968710685975,83.40931367726,83.52035239341829,83.62793557987371,83.7337316876799,83.87333509202729,84.01674600565579,84.15617002736079,84.3062211251976,84.4657926205257,84.7568760515218,85.0489455763758,85.3387531748492,85.6256730500339,85.91029475330721,86.0825663313784,86.2475979610618,86.4065471115508,86.5683218643055,,
Europe & Central Asia (developing only),ECA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,69.6359592667916,70.4600339562825,71.2886649926986,71.72330965560491,72.15319413569149,72.5736113115355,72.9861180502796,73.3953145768021,73.6855250426004,73.9781846721995,74.2735331666955,74.5777283378747,74.8903345152714,75.0589124872472,75.2307196095702,75.40460801380542,75.5796988991976,75.75651770440459,75.9383184494766,76.12758945552,76.327983638533,76.5402678520146,76.75942833644629,77.0474908645375,77.3379079873121,77.6291485654297,77.92248324478021,78.2186300009177,78.12000328267159,78.02328612450029,77.9298676213753,77.8429058748362,77.76415559812621,77.8410502319099,77.9259616267369,78.01776801829479,78.115938180448,78.22252983733699,78.5556298612422,78.89000612000629,79.22230917470091,79.55233423530329,79.8839650477013,80.19160070439558,80.4995189284342,80.80872032897192,81.117078265884,81.42338567493479,81.6460695452845,81.86516906825959,82.0842636091233,82.30521360343529,,
Europe and Central Asia (IFC classification),CEU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
European Union,EUU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.79010187671909,79.32041645851159,79.8524776327929,80.12400303619009,80.39591148037391,80.66908064389109,80.9417251959192,81.21235561855092,81.46276861819659,81.7143053212346,81.96657325230491,82.2188769963747,82.47035437443171,82.7511143531833,83.0322181513635,83.313500707822,83.5976469209795,83.8853584014044,84.14820810400991,84.4108688988512,84.67157419665921,84.9304206625502,85.1869669268009,85.4075007398891,85.6278594724657,85.8489608758257,86.0713765537262,86.29483833719891,86.4902925315588,86.6880416652355,86.8858326085997,87.0839391273845,87.2815865760878,87.5092783373991,87.73612080269709,87.963319761296,88.1919402577205,88.4206967068445,88.6489701495303,88.87706551237079,89.1069556024405,89.3419921548893,89.5766999653339,89.77857338386221,89.9813338535402,90.18418550968971,90.38738465062892,90.5918068112921,90.7327370554476,90.87128109228,91.00927434856409,91.1529629171198,,
Faeroe Islands,FRO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Fiji,FJI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,56.7498,57.28224,57.814676,58.29747,58.78025,59.26304,59.74583,60.228624,60.66705,61.10547,61.54389,61.98232,62.420738,62.79911,63.17748,63.55585,63.93423,64.312591,64.73795,65.1633,65.58865,66.01401,66.439359,66.82307,67.20679,67.5905,67.97421,68.357919,68.70576,69.05361,69.40146,69.74931,70.097153,70.41403,70.73091,71.04779,71.36467,71.681561,71.9716,72.26165,72.5517,72.84174,73.131783,73.5618,73.99181,74.42183,74.85184,75.281853,75.6538,76.02575,76.3977,76.76965,,
Finland,FIN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,79.1378,79.55588,79.973951,80.30105,80.62814,80.95524,81.28233,81.60944,82.05077,82.49209,82.93341,83.37473,83.81606,84.25262,84.68917,85.12572,85.56228,85.998848,86.37275,86.74665,87.12055,87.49445,87.86835,87.9599,88.05145,88.14301,88.23456,88.32611,88.49627,88.66643,88.83659,89.00674,89.176899,89.39229,89.60767,89.82306,90.03844,90.253842,90.34793,90.44202,90.5361,90.63019,90.724288,90.79984,90.8754,90.95095,91.0265,91.102063,91.23825,91.37444,91.51064,91.64683,,
France,FRA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,80.21283,80.7239,81.234959,81.47592,81.71689,81.95786,82.19882,82.439781,82.74223,83.04467,83.34711,83.64956,83.952022,84.30804,84.66405,85.02006,85.37607,85.73209,86.01823,86.30436,86.59049,86.87663,87.162761,87.42681,87.69086,87.95492,88.21897,88.483028,88.68699,88.89095,89.0949,89.29886,89.50283,89.66172,89.82061,89.9795,90.13839,90.297286,90.43076,90.56425,90.69773,90.83121,90.964689,91.08923,91.21376,91.33829,91.46283,91.587354,91.71814,91.84892,91.97971,92.11049,,
French Polynesia,PYF,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,50.36311,51.24918,52.135252,53.05023,53.9652,54.88018,55.79515,56.71013,57.35214,57.99415,58.63616,59.27817,59.920188,60.56319,61.20618,61.84918,62.49218,63.135186,64.56376,65.99232,67.42089,68.84946,70.278032,70.78728,71.29653,71.80578,72.31503,72.824284,73.13382,73.44336,73.7529,74.06244,74.371977,75.39259,76.41319,77.4338,78.45441,79.475021,80.12257,80.77011,81.41766,82.0652,82.712737,83.20303,83.69333,84.18362,84.67392,85.16423,85.44627,85.72832,86.01036,86.2924,,
Gabon,GAB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,33.02393,33.42854,33.833143,34.97503,36.11691,37.2588,38.40068,39.542566,40.68954,41.83651,42.98348,44.13046,45.277421,46.42694,47.57645,48.72597,49.87549,51.025002,52.26052,53.49604,54.73155,55.96707,57.202589,58.32827,59.45396,60.57964,61.70532,62.831007,63.0179,63.2048,63.39169,63.57858,63.765483,63.37001,62.97454,62.57906,62.18359,61.788114,61.12624,60.46437,59.80249,59.14062,58.478752,59.04604,59.61333,60.18063,60.74792,61.315214,61.94552,62.57583,63.20614,63.83645,,
"Gambia, The",GMB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,22.72253,23.04693,23.371342,24.01485,24.65835,25.30186,25.94536,26.588871,27.82194,29.05502,30.28809,31.52116,32.754235,33.99592,35.23761,36.47929,37.72097,38.962663,40.16156,41.36045,42.55935,43.75824,44.957143,45.90786,46.85859,47.80931,48.76003,49.710746,50.02523,50.33971,50.65419,50.96867,51.283149,51.70077,52.11839,52.536,52.95362,53.371233,53.83614,54.30104,54.76595,55.23085,55.69575,56.13097,56.56619,57.00141,57.43663,57.871844,58.26682,58.66179,59.05676,59.45173,,
Georgia,GEO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,72.63289,73.31843,74.003953,74.61555,75.22715,75.83875,76.45034,77.061943,77.4921,77.92226,78.35242,78.78259,79.212748,79.63863,80.06451,80.49039,80.91628,81.342159,81.32543,81.30871,81.29198,81.27526,81.258531,81.48415,81.70978,81.9354,82.16103,82.386648,82.39664,82.40662,82.41661,82.4266,82.436599,82.65638,82.87616,83.09594,83.31572,83.535497,83.91426,84.29303,84.6718,85.05057,85.429332,85.66582,85.90232,86.13882,86.37531,86.611799,86.77043,86.92906,87.08769,87.24632,,
Germany,DEU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,79.36324,79.70031,80.037373,80.24467,80.45198,80.65929,80.86659,81.073894,81.26781,81.46172,81.65562,81.84953,82.043452,82.36967,82.69589,83.02211,83.34833,83.674555,84.00276,84.33097,84.65918,84.98739,85.315604,85.63707,85.95853,86.28,86.60146,86.922918,87.11407,87.30521,87.49636,87.68751,87.878649,88.16212,88.4456,88.72908,89.01256,89.296035,89.52055,89.74506,89.96957,90.19408,90.418599,90.56035,90.7021,90.84386,90.98561,91.127362,91.2564,91.38544,91.51449,91.64353,,
Ghana,GHA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,40.02514,40.72216,41.419185,41.94185,42.46451,42.98717,43.50984,44.032505,44.63922,45.24594,45.85265,46.45937,47.066082,47.52419,47.9823,48.44041,48.89853,49.356639,49.76653,50.17642,50.58631,50.9962,51.406094,52.03743,52.66877,53.3001,53.93144,54.562768,55.36293,56.1631,56.96326,57.76342,58.56359,57.9795,57.39542,56.81133,56.22724,55.643159,55.70505,55.76694,55.82883,55.89072,55.952614,56.85685,57.76109,58.66533,59.56957,60.473804,60.8151,61.15639,61.49768,61.83898,,
Greece,GRC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.89981,77.6338,78.36778,78.67818,78.98859,79.29899,79.60939,79.919784,80.31283,80.70587,81.09892,81.49196,81.88499,82.21117,82.53735,82.86353,83.1897,83.515876,84.07235,84.62882,85.1853,85.74177,86.298255,86.54906,86.79986,87.05066,87.30146,87.552254,88.15571,88.75916,89.36262,89.96607,90.569531,90.72305,90.87656,91.03008,91.1836,91.337107,91.53606,91.73501,91.93396,92.13291,92.331847,92.39924,92.46663,92.53402,92.60141,92.668791,92.77762,92.88644,92.99527,93.1041,,
Greenland,GRL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Grenada,GRD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,64.15874,64.73248,65.30622,65.8066,66.30698,66.80737,67.30775,67.80812,68.2449,68.68169,69.11847,69.55525,69.99203,70.37438,70.75673,71.13908,71.52142,71.90378,72.23995,72.57613,72.9123,73.24847,73.58465,73.88066,74.17667,74.47269,74.7687,75.06472,75.32757,75.59042,75.85326,76.11611,76.37897,76.61348,76.84799,77.0825,77.31702,77.55153,77.91927,78.28701,78.65475,79.02248,79.39023,79.76553,80.14084,80.51614,80.89145,81.26676,81.50683,81.74689,81.98696,82.22703,,
Guam,GUM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,64.11968,64.92593,65.732164,66.51916,67.30615,68.09315,68.88014,69.667135,70.38956,71.112,71.83443,72.55687,73.279292,73.88449,74.48969,75.09489,75.7001,76.305291,76.82963,77.35397,77.8783,78.40264,78.926972,79.38198,79.83699,80.292,80.74701,81.202021,81.5927,81.98339,82.37408,82.76476,83.155455,83.62125,84.08705,84.55285,85.01865,85.484451,85.98767,86.49089,86.99411,87.49733,88.000544,88.41399,88.82745,89.2409,89.65435,90.067793,90.30913,90.55046,90.79179,91.03313,,
Guatemala,GTM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,38.7634,39.6902,40.617,41.622,42.627,43.632,44.637,45.642,46.8996,48.1572,49.4148,50.6724,51.93,52.7086,53.4872,54.2658,55.0444,55.823,56.5874,57.3518,58.1162,58.8806,59.645,60.5288,61.4126,62.2964,63.1802,64.064,64.9484,65.8328,66.7172,67.6016,68.486,69.4194,70.35281,71.28621,72.21961,73.153,73.8624,74.57179,75.28119,75.99059,76.7,77.0026,77.3052,77.6078,77.91039,78.213,78.64396,79.07492,79.50588,79.93684,,
Guinea,GIN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,26.41512,26.71732,27.019516,27.2554,27.49129,27.72717,27.96306,28.198946,28.6175,29.03606,29.45462,29.87318,30.291735,30.97684,31.66194,32.34705,33.03215,33.717256,34.69743,35.67761,36.65778,37.63796,38.618134,40.22141,41.82468,43.42795,45.03122,46.634493,47.52485,48.41521,49.30557,50.19593,51.086288,50.66875,50.25121,49.83368,49.41614,48.998595,48.48696,47.97533,47.46369,46.95206,46.440424,47.69711,48.9538,50.21048,51.46717,52.723858,53.15707,53.59028,54.02349,54.45671,,
Guinea-Bissau,GNB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,36.13674,36.5167,36.896655,37.2677,37.63874,38.00979,38.38083,38.751874,39.11512,39.47837,39.84163,40.20488,40.568123,40.89244,41.21675,41.54106,41.86537,42.189684,42.63633,43.08297,43.52961,43.97625,44.422893,44.97491,45.52693,46.07895,46.63096,47.182981,47.78413,48.38527,48.98642,49.58757,50.188707,50.27001,50.35131,50.43261,50.51392,50.595217,50.34061,50.086,49.83139,49.57678,49.322167,49.94958,50.577,51.20441,51.83183,52.459249,52.80496,53.15068,53.49639,53.84211,,
Guyana,GUY,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,59.94569,60.22698,60.508272,60.78138,61.0545,61.32761,61.60072,61.873829,62.13879,62.40374,62.6687,62.93366,63.198624,63.45549,63.71235,63.9692,64.22607,64.482927,64.73177,64.98061,65.22945,65.47829,65.727128,65.95936,66.19159,66.42382,66.65605,66.888274,67.12465,67.36102,67.5974,67.83377,68.070156,68.25375,68.43733,68.62092,68.8045,68.988098,69.09765,69.2072,69.31675,69.4263,69.535854,69.6033,69.67075,69.73819,69.80563,69.87308,70.21637,70.55966,70.90295,71.24625,,
Haiti,HTI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,35.64109,36.23941,36.83774,37.40207,37.96639,38.53072,39.09505,39.659369,40.08557,40.51178,40.93798,41.36419,41.790383,42.57097,43.35156,44.13215,44.91274,45.693328,46.20193,46.71054,47.21915,47.72776,48.236369,48.79641,49.35644,49.91648,50.47651,51.036545,51.57268,52.10882,52.64495,53.18109,53.717229,54.25108,54.78492,55.31877,55.85262,56.386463,56.6773,56.96813,57.25896,57.54979,57.840621,58.63894,59.43725,60.23556,61.03387,61.832182,62.59817,63.36415,64.13013,64.89612,,
Heavily indebted poor countries (HIPC),HPC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,32.5382201042353,33.123565843943,33.7097012472922,34.2495528432607,34.789482799507,35.329517987512496,35.869837890823796,36.4104959080612,37.004284501383204,37.597353646547,38.189816770066,38.7823629756366,39.375561096598396,39.9415765028808,40.507239674208,41.0728014355751,41.6377074933054,42.2027818913512,42.6395093332768,43.08244824190621,43.532610809762,43.9891876830503,44.4492762667643,44.831197386264805,45.2067809046552,45.573788637427995,45.9324394498795,46.283621116857994,46.27030990501821,46.251518343956604,46.2386972780338,46.244350241747,46.275327012377794,46.349847524617005,46.407283382011606,46.4458078885712,46.47000706886,46.4883868262191,46.8618880136386,47.2362590990588,47.61468927335879,47.99773507973,48.3845711935289,49.4120905710324,50.4383198401102,51.4630859867994,52.487100650830705,53.5108427261033,54.458796777753,55.4074230321416,56.357486308458995,57.309872107183196,,
High income,HIC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,77.05527099321529,77.5926661709405,78.1339345291684,78.4664145884407,78.7995547508747,79.132477678885,79.4644009246516,79.79480741483371,80.081590705492,80.3729399980052,80.6625842728235,80.9537008846887,81.24714549535379,81.5473879251309,81.853868237306,82.16160718134059,82.4690218697553,82.78167245476659,83.04877964298329,83.31791240805241,83.5884473064983,83.8610433419834,84.1349370410675,84.41196510866891,84.6895513677321,84.9696991527331,85.2525791957476,85.5366088383422,85.653510771865,85.7729200318707,85.8940615265904,86.0175785874364,86.14706370091992,86.3072997679952,86.4655015028698,86.6185323081837,86.77183031461809,86.920666822782,87.04702283671709,87.1755221804595,87.3010179956604,87.4340021401317,87.5731715439274,87.80101434070959,88.02887171403209,88.2546662270147,88.4792370048488,88.7024161202482,88.8503994582281,88.99635978217329,89.1385483502862,89.28586378420809,,
High income: nonOECD,NOC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,75.0315125348611,75.86754045782259,76.70442588324191,77.0328904981108,77.363031161615,77.69425195291299,78.0206731885479,78.3484832904772,78.4526699358707,78.55828256910858,78.6662589214109,78.7763328829359,78.8886716936626,78.7642205784084,78.6430232921481,78.5265690559477,78.41329696414391,78.3047375296473,78.3362059620879,78.3745917046899,78.40922407215429,78.44633734094771,78.48553993501099,78.8937444638586,79.3045529112815,79.7203453397525,80.1424897517928,80.570061327528,80.21586940667129,79.86998357660009,79.52993554071179,79.18799937819159,78.8188058277095,78.756686774382,78.6947915237936,78.67201953749141,78.6191704177551,78.564089113791,78.4607419835813,78.3599035483184,78.25121887619241,78.1635369945941,78.0816046752927,78.5744173875802,79.0813071415835,79.588911447809,80.09869371257591,80.6083081127985,80.8840128140063,81.1487488147998,81.4019089529188,81.6425973876462,,
High income: OECD,OEC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,77.50927526303721,77.97684296772721,78.45136978466459,78.784460633257,79.11839607395329,79.4522410134534,79.78485428322699,80.1158332329994,80.44380013760801,80.7762757465745,81.1069128264064,81.4387104989811,81.77274694039129,82.168444636412,82.5693342771859,82.9697847388294,83.36942758037,83.77226594597859,84.0871406889016,84.4032737531453,84.72169730206691,85.0427506822774,85.3655604243813,85.6119860135895,85.8607210623157,86.11136872344801,86.3632937736726,86.6159470798539,86.83479922556299,87.0538881004945,87.2709837948546,87.486395437723,87.7012491127047,87.90289047780209,88.1045396434795,88.30554651481441,88.50582964146099,88.7050517791784,88.8909462229598,89.0764520281249,89.2629261304762,89.45052767954691,89.63816661927972,89.80594116107059,89.9729514027487,90.1401264880393,90.30783035085942,90.47703483712989,90.6078335089795,90.7378903722115,90.8677342372748,90.99969540107159,,
Honduras,HND,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,41.5346,42.5818,43.629,44.538,45.447,46.356,47.265,48.174,49.0878,50.0016,50.9154,51.8292,52.743,53.7642,54.7854,55.80659,56.82779,57.849,58.999,60.149,61.299,62.44901,63.599,64.775,65.951,67.12701,68.30301,69.479,70.1384,70.7978,71.4572,72.1166,72.776,73.3994,74.0228,74.64619,75.26959,75.893,76.204,76.515,76.826,77.13699,77.448,77.7456,78.0432,78.3408,78.6384,78.936,79.33308,79.73015,80.12722,80.52429,,
"Hong Kong SAR, China",HKG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,75.09513,75.97523,76.855327,77.46362,78.07192,78.68022,79.28852,79.896821,80.42474,80.95267,81.48059,82.00851,82.536432,82.99405,83.45167,83.90929,84.36691,84.824511,85.22098,85.61745,86.01392,86.41039,86.806846,87.15033,87.49381,87.8373,88.18078,88.524247,88.82191,89.11958,89.41725,89.71492,90.012591,90.2707,90.5288,90.7869,91.04501,91.303113,91.65815,92.01318,92.36822,92.72325,93.0783,93.20112,93.32394,93.44675,93.56957,93.6924,93.85249,94.01258,94.17267,94.33276,,
Hungary,HUN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.83408,77.46578,78.097481,78.38318,78.66888,78.95457,79.24027,79.525981,79.49867,79.47137,79.44406,79.41676,79.38944,79.3848,79.38015,79.3755,79.37086,79.366221,79.23449,79.10276,78.97103,78.8393,78.70758,78.80454,78.9015,78.99847,79.09543,79.192407,79.19949,79.20656,79.21363,79.2207,79.227787,79.64248,80.05717,80.47186,80.88654,81.301229,81.67681,82.05239,82.42797,82.80355,83.179125,83.43179,83.68446,83.93713,84.1898,84.442462,84.61722,84.79197,84.96672,85.14147,,
Iceland,ISL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,83.75359,84.09194,84.430282,84.39187,84.35345,84.31504,84.27663,84.238203,84.2981,84.35799,84.41788,84.47777,84.537675,84.98888,85.44008,85.89128,86.34248,86.793679,87.14505,87.49642,87.84779,88.19917,88.550553,88.55532,88.56009,88.56486,88.56963,88.574404,88.68957,88.80473,88.9199,89.03506,89.150215,89.35745,89.56469,89.77193,89.97916,90.186384,90.37684,90.56729,90.75774,90.9482,91.13866,91.43696,91.73526,92.03356,92.33186,92.630155,92.72938,92.8286,92.92782,93.02704,,
India,IND,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,28.08454,29.06424,30.043944,31.28387,32.5238,33.76373,35.00366,36.243595,37.56137,38.87914,40.19691,41.51468,42.832463,44.22422,45.61597,47.00772,48.39948,49.791239,50.46422,51.1372,51.81018,52.48317,53.156145,53.62988,54.1036,54.57733,55.05106,55.524792,56.12406,56.72332,57.32259,57.92186,58.521125,59.22646,59.93179,60.63713,61.34246,62.047803,62.78449,63.52118,64.25787,64.99455,65.731239,66.43694,67.14265,67.84835,68.55405,69.259762,69.69322,70.12669,70.56015,70.99361,,
Indonesia,IDN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,38.6368,39.70876,40.78071,41.85693,42.93316,44.00938,45.0856,46.161819,47.22121,48.28061,49.34,50.3994,51.458798,52.43981,53.42082,54.40183,55.38284,56.363856,57.25989,58.15593,59.05196,59.94799,60.844034,61.65597,62.46791,63.27984,64.09178,64.903715,65.63511,66.3665,67.09789,67.82928,68.560682,69.2167,69.87272,70.52874,71.18476,71.84077,72.42741,73.01405,73.60069,74.18732,74.773961,75.29751,75.82105,76.3446,76.86814,77.391691,77.80628,78.22087,78.63546,79.05005,,
"Iran, Islamic Rep.",IRN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,36.14858,37.05846,37.968333,38.91517,39.86201,40.80885,41.75568,42.70252,43.68801,44.6735,45.65899,46.64448,47.629969,48.80952,49.98907,51.16862,52.34817,53.527727,54.73348,55.93924,57.145,58.35075,59.556506,60.6539,61.7513,62.8487,63.94609,65.043493,66.05403,67.06457,68.0751,69.08564,70.096187,71.00629,71.9164,72.82652,73.73663,74.646736,75.53608,76.42542,77.31477,78.20411,79.093436,79.86143,80.62942,81.39741,82.1654,82.933395,83.36479,83.79619,84.22758,84.65898,,
Iraq,IRQ,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,40.65959,42.08693,43.514261,45.10286,46.69145,48.28004,49.86863,51.457233,52.54971,53.64218,54.73465,55.82712,56.919591,57.68344,58.44728,59.21113,59.97498,60.738825,62.17577,63.61271,65.04964,66.48659,67.923523,69.68208,71.44064,73.1992,74.95776,76.716326,77.37022,78.02412,78.67802,79.33192,79.985815,80.16266,80.3395,80.51634,80.69318,80.87004,80.66119,80.45235,80.2435,80.03465,79.825794,79.6405,79.45522,79.26993,79.08464,78.899355,79.18324,79.46713,79.75102,80.03491,,
Ireland,IRL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.676,77.18997,77.703931,77.9649,78.22588,78.48685,78.74782,79.008787,79.19733,79.38587,79.57442,79.76296,79.951495,80.31275,80.67401,81.03527,81.39653,81.75778,82.09399,82.43019,82.7664,83.1026,83.438795,83.79159,84.14438,84.49717,84.84996,85.202765,85.5667,85.93065,86.29459,86.65854,87.022477,87.2392,87.45593,87.67266,87.88939,88.106099,88.38889,88.67168,88.95448,89.23727,89.520052,89.77953,90.03902,90.2985,90.55798,90.817464,90.99628,91.17509,91.3539,91.53271,,
Isle of Man,IMY,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Israel,ISR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.25604,78.53646,78.816865,79.08393,79.351,79.61806,79.88513,80.15219,80.43813,80.72406,81.00999,81.29593,81.581855,81.9034,82.22494,82.54648,82.86802,83.189577,83.5326,83.87563,84.21865,84.56168,84.904689,85.2428,85.58091,85.91902,86.25713,86.59524,86.91774,87.24023,87.56273,87.88522,88.207729,88.50644,88.80515,89.10385,89.40256,89.701264,89.96827,90.23528,90.50228,90.76929,91.036284,91.26863,91.50098,91.73332,91.96567,92.198012,92.31454,92.43106,92.54758,92.66411,,
Italy,ITA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.95616,79.40448,79.85281,80.22523,80.59764,80.97005,81.34247,81.714887,82.08311,82.45132,82.81954,83.18776,83.555988,83.98029,84.4046,84.82891,85.25322,85.67753,86.0163,86.35508,86.69386,87.03263,87.371408,87.66289,87.95437,88.24585,88.53733,88.828818,89.04723,89.26566,89.48408,89.7025,89.920909,90.12969,90.33848,90.54726,90.75605,90.964839,91.19131,91.41778,91.64425,91.87072,92.097177,92.27525,92.45333,92.63141,92.80949,92.987565,93.1314,93.27524,93.41908,93.56291,,
Jamaica,JAM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,69.62321,70.52082,71.418432,71.9602,72.50197,73.04374,73.58551,74.12727,74.5571,74.98692,75.41675,75.84657,76.276404,76.56683,76.85725,77.14767,77.43809,77.728495,77.84155,77.95461,78.06767,78.18073,78.293798,78.32417,78.35455,78.38492,78.41529,78.445661,78.37206,78.29846,78.22486,78.15126,78.077668,78.07168,78.06569,78.0597,78.05371,78.047706,78.1712,78.2947,78.4182,78.54169,78.665176,79.00612,79.34706,79.688,80.02895,80.369878,80.62668,80.88348,81.14027,81.39707,,
Japan,JPN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,75.34566,76.3994,77.453121,78.23763,79.02213,79.80664,80.59115,81.375658,81.96359,82.55153,83.13947,83.7274,84.315341,84.91851,85.52168,86.12484,86.728,87.331175,87.72444,88.11771,88.51099,88.90426,89.297521,89.58577,89.87402,90.16226,90.45051,90.738769,90.89946,91.06015,91.22084,91.38153,91.542226,91.64873,91.75523,91.86172,91.96822,92.074738,92.23383,92.39293,92.55202,92.71112,92.870213,92.96095,93.0517,93.14244,93.23318,93.323919,93.44654,93.56916,93.69178,93.8144,,
Jordan,JOR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,49.19252,50.2893,51.386078,52.59894,53.81181,55.02467,56.23753,57.450397,58.67369,59.89698,61.12027,62.34356,63.566846,64.65665,65.74645,66.83626,67.92606,69.015858,69.78788,70.5599,71.33192,72.10394,72.875954,73.48904,74.10213,74.71523,75.32832,75.94139,76.37389,76.80638,77.23888,77.67137,78.103866,78.38705,78.67024,78.95343,79.23662,79.519815,79.83724,80.15467,80.4721,80.78953,81.10696,81.38847,81.66999,81.95151,82.23302,82.514542,82.75546,82.99637,83.23728,83.4782,,
Kazakhstan,KAZ,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,66.70678,67.32774,67.948706,68.56692,69.18513,69.80334,70.42155,71.03976,71.4826,71.92544,72.36828,72.81112,73.25396,73.5441,73.83424,74.12437,74.41451,74.70464,75.16467,75.62469,76.08472,76.54475,77.004784,77.34667,77.68856,78.03045,78.37234,78.714219,77.77377,76.83333,75.89288,74.95244,74.012,73.35732,72.70264,72.04797,71.39329,70.73861,71.27169,71.80477,72.33785,72.87093,73.404,73.81775,74.2315,74.64525,75.059,75.472732,75.72167,75.97061,76.21955,76.46849,,
Kenya,KEN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,43.02343,44.03111,45.03879,45.80561,46.57243,47.33924,48.10606,48.872878,49.71216,50.55145,51.39073,52.23001,53.0693,53.81121,54.55312,55.29504,56.03695,56.77886,57.55941,58.33995,59.12049,59.90104,60.681583,60.82401,60.96643,61.10885,61.25127,61.3937,60.82813,60.26256,59.69699,59.13142,58.565845,56.77137,54.97689,53.18242,51.38794,49.593459,48.85932,48.12518,47.39104,46.65691,45.922769,47.54656,49.17035,50.79413,52.41792,54.041709,55.87779,57.71387,59.54996,61.38604,,
Kiribati,KIR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,42.52607,43.17196,43.817864,44.45219,45.08652,45.72086,46.35519,46.989512,47.65007,48.31063,48.9712,49.63176,50.292315,50.9708,51.64928,52.32776,53.00624,53.684724,54.3797,55.07468,55.76966,56.46465,57.15963,58.11291,59.06618,60.01946,60.97274,61.926018,62.63824,63.35046,64.06269,64.77492,65.487139,66.17717,66.8672,67.55724,68.24727,68.937303,69.51452,70.09174,70.66895,71.24617,71.823389,72.35063,72.87788,73.40512,73.93237,74.459598,75.04897,75.63834,76.22771,76.81709,,
"Korea, Dem. Rep.",PRK,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,46.47669,47.18643,47.896169,49.66559,51.43501,53.20442,54.97384,56.743259,58.31494,59.88662,61.45829,63.02997,64.601659,65.75543,66.9092,68.06297,69.21674,70.370517,71.06552,71.76053,72.45554,73.15054,73.84555,74.37099,74.89644,75.42188,75.94733,76.472787,77.43046,78.38813,79.3458,80.30347,81.26113,79.33085,77.40057,75.47028,73.54,71.609723,72.62762,73.64551,74.6634,75.68129,76.699175,76.8,76.90081,77.00163,77.10244,77.20326,77.69464,78.18602,78.6774,79.16878,,
"Korea, Rep.",KOR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,50.76272,52.02527,53.287826,54.71809,56.14836,57.57863,59.0089,60.439169,62.06027,63.68138,65.30248,66.92358,68.544687,69.32082,70.09695,70.87308,71.64921,72.425325,73.2776,74.12987,74.98214,75.83441,76.686693,77.73733,78.78796,79.83858,80.88921,81.93985,82.66256,83.38527,84.10798,84.83069,85.553385,86.14587,86.73834,87.33082,87.92329,88.515781,89.03074,89.5457,90.06066,90.57562,91.090581,91.57007,92.04956,92.52905,93.00854,93.488027,93.75723,94.02644,94.29564,94.56484,,
Kosovo,KSV,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Kuwait,KWT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,65.91242,66.99698,68.081534,68.94748,69.81342,70.67937,71.54531,72.41125,73.09276,73.77427,74.45578,75.13729,75.818786,76.34193,76.86507,77.38821,77.91135,78.434504,78.90378,79.37305,79.84233,80.31161,80.780892,81.16145,81.54202,81.92258,82.30314,82.683689,82.94329,83.20289,83.46249,83.72208,83.981683,84.18703,84.39237,84.59772,84.80306,85.008391,85.1851,85.36182,85.53853,85.71524,85.891941,86.05434,86.21674,86.37914,86.54153,86.703934,86.87095,87.03796,87.20498,87.37199,,
Kyrgyz Republic,KGZ,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,61.16992,61.82688,62.483848,63.14371,63.80358,64.46345,65.12331,65.783181,66.26931,66.75543,67.24155,67.72768,68.21381,68.53075,68.84769,69.16463,69.48158,69.798523,70.28625,70.77399,71.26172,71.74945,72.237182,72.73836,73.23954,73.74072,74.24191,74.743078,74.85106,74.95905,75.06703,75.17502,75.282992,74.93078,74.57857,74.22636,73.87415,73.521923,73.65433,73.78673,73.91913,74.05153,74.183935,74.53841,74.89289,75.24737,75.60184,75.95633,76.19896,76.44159,76.68422,76.92685,,
Lao PDR,LAO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,36.35127,36.74214,37.132997,37.51696,37.90092,38.28489,38.66885,39.052821,39.4635,39.87418,40.28485,40.69553,41.106208,41.45573,41.80526,42.15479,42.50432,42.853846,43.27024,43.68663,44.10302,44.51941,44.935795,45.62938,46.32296,47.01655,47.71013,48.403722,49.56469,50.72567,51.88664,53.04761,54.208586,55.40324,56.59789,57.79255,58.9872,60.181853,61.20933,62.23681,63.26429,64.29176,65.319246,66.16718,67.0151,67.86302,68.71095,69.558874,70.36774,71.17661,71.98548,72.79435,,
Latin America & Caribbean (all income levels),LCN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,56.877838977346,57.6526339712112,58.42801015680321,59.04407621138571,59.658162330443496,60.269508771435795,60.8782918494579,61.4851607384581,62.1214374585659,62.75989538092811,63.4019533796716,64.0478146156452,64.69700103597451,65.3475695805553,65.9998934061105,66.6534775808531,67.3085824792185,67.96518402165471,68.75997928727351,69.556396038591,70.3544816585698,71.1539552435059,71.955270424281,72.4917973215998,73.0301766044057,73.5704509428512,74.1127479184214,74.6567498838004,75.12716940754741,75.59882567773721,76.0715729370308,76.5455189198439,77.02072745883609,77.4267979463619,77.83193327440449,78.235363658892,78.6368761575879,79.0366452251652,79.389444639215,79.740658471958,80.093172587324,80.44722096392,80.8024936384186,81.1135148442903,81.42486587010191,81.73621158029779,82.04746409637201,82.3587460300023,82.6346224110293,82.91058627351359,83.1866058885795,83.4626632340305,,
Latin America & Caribbean (developing only),LAC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,56.26982894790049,57.0592469507601,57.8479538162862,58.4693518622653,59.089957075652,59.7097946303051,60.328983114564,60.9479206425311,61.591456950726396,62.236641382076996,62.884133879550504,63.53407816911079,64.1863774931565,64.82918693683621,65.4740227815818,66.1207125303365,66.7693741422919,67.41997977882811,68.2213604344333,69.02436478459799,69.828843727586,70.6345987007854,71.442024970577,71.99162996095279,72.5427961935307,73.0956941886928,73.65025542311758,74.2062187008689,74.6901722762018,75.1753977091596,75.6617544493304,76.14958118226849,76.6387008924609,77.0552005262759,77.4703073393222,77.8831765321252,78.29344664031191,78.70161940508109,79.05287074204459,79.4044549169878,79.7572975520627,80.11153968923321,80.46682035886009,80.78667487487009,81.1066661595469,81.426520206677,81.7462124559963,82.065847508541,82.34852236760841,82.63132044903091,82.9142727247075,83.1974547695099,,
Latin America and the Caribbean (IFC classification),CLA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Latvia,LVA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.93214,79.66251,80.392885,80.66556,80.93823,81.21091,81.48358,81.756252,81.66347,81.57068,81.47789,81.3851,81.292325,81.11719,80.94205,80.76691,80.59177,80.416624,80.38829,80.35995,80.33162,80.30328,80.274941,80.52451,80.77409,81.02366,81.27323,81.52281,80.96404,80.40527,79.8465,79.28773,78.728969,78.93263,79.13629,79.33995,79.54361,79.747275,80.25713,80.76698,81.27684,81.7867,82.296543,82.43647,82.5764,82.71633,82.85626,82.996192,83.12853,83.26087,83.39321,83.52555,,
Least developed countries: UN classification,LDC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,33.4443880167779,34.0531268333161,34.661571836997396,35.2870286074626,35.915121985777205,36.5474042075395,37.1853215993951,37.8277031982174,38.144564658940894,38.453581363831795,38.7540903194248,39.048044910575,39.3394623804537,40.018104890949004,40.6955865800714,41.3788767112231,42.074045469032995,42.78387689064971,43.485963740155604,44.1807970733298,44.867569827887,45.5484400279457,46.2265027668299,46.7488232391415,47.2690852203337,47.7871964416548,48.303560819253505,48.817832718649996,49.108994876713,49.3952941277924,49.6816838589151,49.97410517443729,50.2769010614704,50.6845371691551,51.0829718870554,51.475177260405594,51.867045338555606,52.2631746665409,52.834102948426896,53.4002736753024,53.9584354136968,54.5073484359265,55.0480872255419,55.91354293011349,56.773806232164496,57.6311750979715,58.486848105835506,59.3408140768321,60.146299570045,60.9529985494205,61.7620555990329,62.574445231618995,,
Lebanon,LBN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,66.55661,67.0826,67.608612,68.0503,68.49199,68.93368,69.37537,69.817049,70.2789,70.74075,71.20261,71.66446,72.126311,72.42392,72.72153,73.01913,73.31674,73.61435,73.85334,74.09232,74.33131,74.57029,74.809282,75.20668,75.60407,76.00146,76.39886,76.796259,77.24192,77.68758,78.13325,78.57891,79.024566,79.77908,80.5336,81.28812,82.04263,82.797152,83.56922,84.34129,85.11337,85.88544,86.657496,87.41039,88.16328,88.91618,89.66907,90.421969,90.70681,90.99165,91.2765,91.56134,,
Lesotho,LSO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,40.40231,41.16982,41.93733,42.14306,42.3488,42.55453,42.76027,42.965997,43.31479,43.66359,44.01239,44.36118,44.709983,45.41038,46.11078,46.81118,47.51157,48.211979,49.13597,50.05996,50.98394,51.90793,52.831917,53.44531,54.05871,54.6721,55.2855,55.898887,56.71257,57.52625,58.33994,59.15362,59.967305,56.26876,52.57021,48.87166,45.17311,41.474564,37.67937,33.88418,30.08899,26.29379,22.498604,23.23542,23.97223,24.70904,25.44585,26.182663,27.33272,28.48277,29.63282,30.78288,,
Liberia,LBR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,27.56866,27.88557,28.202475,28.75815,29.31383,29.86951,30.42519,30.980866,31.79336,32.60586,33.41836,34.23085,35.043353,36.31452,37.58568,38.85685,40.12801,41.399169,42.19327,42.98737,43.78148,44.57558,45.369674,45.6694,45.96912,46.26884,46.56856,46.868283,46.95554,47.04279,47.13005,47.2173,47.304557,48.22365,49.14274,50.06184,50.98093,51.900018,51.25476,50.60951,49.96426,49.31901,48.673752,50.48372,52.29369,54.10365,55.91362,57.723589,58.43192,59.14025,59.84859,60.55692,,
Libya,LBY,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,38.49827,40.62296,42.74765,44.59901,46.45038,48.30174,50.15311,52.004468,53.67989,55.3553,57.03072,58.70613,60.381552,61.62438,62.8672,64.11003,65.35286,66.595681,67.54856,68.50144,69.45432,70.4072,71.360099,71.957,72.5539,73.1508,73.7477,74.344621,74.91491,75.4852,76.05549,76.62578,77.196054,77.7211,78.24615,78.77119,79.29624,79.821274,80.37672,80.93217,81.48763,82.04308,82.59853,83.08542,83.57231,84.0592,84.5461,85.032975,85.28262,85.53226,85.7819,86.03154,,
Liechtenstein,LIE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lithuania,LTU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,77.59679,78.42561,79.254407,79.74644,80.23848,80.73051,81.22255,81.71458,81.86755,82.02052,82.17348,82.32645,82.479413,82.3884,82.29738,82.20636,82.11534,82.024319,81.96198,81.89965,81.83732,81.77499,81.712652,81.96418,82.21571,82.46723,82.71876,82.970273,82.63552,82.30077,81.96601,81.63126,81.296497,81.47354,81.65058,81.82762,82.00466,82.181714,82.57909,82.97646,83.37383,83.77119,84.168569,84.05779,83.94701,83.83623,83.72545,83.614662,83.76144,83.90823,84.05501,84.20179,,
Low & middle income,LMY,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,41.2544206663193,41.94944281720171,42.6300570353936,44.4200540209681,46.2157370427742,48.0108306296554,49.8127278842684,51.61692377494221,52.701268380837604,53.7872488150051,54.8721490816567,55.956647077099596,57.032541060277005,57.81028329296021,58.5886113219534,59.36823932861321,60.1515255550199,60.9383850338001,61.5571286539503,62.1807142683058,62.80605045255611,63.4351933710238,64.0725129387523,64.5844400634334,65.0880932868365,65.5867984955071,66.08283207123961,66.5762550883013,66.9625297617059,67.3404875153427,67.7134517155398,68.0789152975209,68.4386694725379,68.74158020440021,69.0453293831012,69.3526730350251,69.66544582782011,69.98410738908,70.42386361639579,70.8650334554614,71.30634141147341,71.7484533911079,72.19514988762391,72.6614280004515,73.12563766993709,73.5856064634664,74.040167198538,74.4895828409821,74.88980924311991,75.2851505063108,75.67488413362291,76.06123711233009,,
Low income,LIC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,35.212734627152294,35.8298841467316,36.445817981233894,37.1395341768108,37.833739402060296,38.5283905364952,39.2243604843533,39.9204732937364,40.2669645231368,40.6094249677927,40.9506131806145,41.295780078569,41.648609294050004,42.3679299194595,43.085779572080796,43.80421692560449,44.527257620288204,45.2592115988294,45.981852632921296,46.7012137407874,47.419360910851005,48.138877310415104,48.8608367688103,49.4002218464235,49.93535045069079,50.4632959445914,50.9846549792548,51.499167685862396,51.7508098680342,51.98853840747599,52.215518713983094,52.437124310490105,52.6588157696381,52.74397301362221,52.82347388530889,52.9051286333465,52.9944458138641,53.09466889470261,53.5623087041866,54.0265427109132,54.4834175650849,54.931775906474506,55.3732850076155,56.23384595067821,57.09363034584639,57.95429026432551,58.8165842917181,59.6796375996078,60.5937588120545,61.5051414483204,62.4150277696769,63.3258403891014,,
Lower middle income,LMC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,38.4920633998981,39.385083069404004,40.2812908209527,41.2433807480664,42.2084864540274,43.1689546501894,44.1266477635923,45.082335259199,45.98429867267551,46.8869555438512,47.785909767214896,48.6900697355118,49.5999229478746,50.6535189702706,51.706250195814,52.7583395051285,53.8093227083834,54.85985166809711,55.4646682578181,56.0725849571441,56.68409715593929,57.296171355528706,57.9129235461195,58.38495067484649,58.857504327559006,59.3309662005677,59.8067420445871,60.2827492462221,60.7360017676752,61.1887812419823,61.6480044517011,62.095975398422205,62.543891325960296,62.9938284326127,63.4432197015116,63.895345849311106,64.3526232104154,64.8149360626321,65.3334584286527,65.85202974503679,66.3664567038408,66.8755671190542,67.3869154927263,67.9316909197162,68.4775716351778,69.0239701573169,69.5707711007602,70.117178974225,70.5078306312447,70.89702236851791,71.28386293091559,71.6686562444248,,
Luxembourg,LUX,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.27306,78.81185,79.350651,79.5318,79.71295,79.8941,80.07526,80.256395,80.3226,80.3888,80.455,80.5212,80.587414,81.06864,81.54987,82.03109,82.51231,82.993542,83.19669,83.39984,83.60299,83.80614,84.009291,84.5301,85.0509,85.57171,86.09251,86.613315,86.74531,86.8773,87.0093,87.1413,87.273284,87.55029,87.8273,88.10431,88.38132,88.65832,88.8978,89.13728,89.37676,89.61624,89.855728,89.97835,90.10097,90.22359,90.34621,90.468812,90.61094,90.75307,90.8952,91.03732,,
"Macao SAR, China",MAC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,69.36064,70.2434,71.126149,71.90642,72.68669,73.46696,74.24724,75.027506,75.71213,76.39674,77.08136,77.76598,78.4506,79.04778,79.64495,80.24213,80.8393,81.436466,81.95496,82.47345,82.99194,83.51044,84.028928,84.47749,84.92606,85.37462,85.82318,86.271741,86.65874,87.04574,87.43274,87.81974,88.206733,88.53992,88.87312,89.20631,89.5395,89.872706,90.15914,90.44558,90.73202,91.01846,91.304891,91.55087,91.79684,92.04282,92.2888,92.534779,92.6812,92.82761,92.97403,93.12045,,
"Macedonia, FYR",MKD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,61.50647,62.64655,63.786614,64.93272,66.07883,67.22495,68.37106,69.517152,70.43405,71.35095,72.26785,73.18475,74.101647,74.6067,75.11175,75.6168,76.12185,76.626912,76.75774,76.88856,77.01938,77.1502,77.281034,77.80146,78.32188,78.84231,79.36273,79.883158,80.17919,80.47522,80.77125,81.06728,81.363317,81.8382,82.31308,82.78796,83.26285,83.737726,84.17584,84.61396,85.05208,85.4902,85.928312,86.01595,86.10358,86.19121,86.27884,86.366463,86.57259,86.77871,86.98483,87.19096,,
Madagascar,MDG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,32.0636,32.67221,33.280817,33.88578,34.49075,35.09572,35.70069,36.305658,36.96034,37.61502,38.2697,38.92439,39.579065,40.25117,40.92327,41.59538,42.26748,42.939584,43.46931,43.99903,44.52876,45.05848,45.588203,45.6711,45.75399,45.83688,45.91978,46.002663,46.88077,47.75888,48.63699,49.5151,50.3932,51.25685,52.1205,52.98415,53.84781,54.711451,55.81807,56.9247,58.03132,59.13795,60.244568,60.9458,61.64703,62.34826,63.04948,63.750706,64.50193,65.25316,66.00439,66.75562,,
Malawi,MWI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,31.70568,32.0509,32.39612,32.71125,33.02637,33.3415,33.65662,33.971744,34.6129,35.25405,35.8952,36.53635,37.177509,37.67328,38.16905,38.66482,39.16059,39.656359,40.23669,40.81703,41.39736,41.9777,42.558034,42.95301,43.34798,43.74296,44.13793,44.532911,44.52082,44.50874,44.49665,44.48457,44.47248,43.49727,42.52206,41.54684,40.57163,39.596416,39.05444,38.51246,37.97049,37.42851,36.886528,38.19209,39.49765,40.80321,42.10877,43.414341,44.56091,45.70747,46.85403,48.0006,,
Malaysia,MYS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,57.42439,58.4005,59.376601,60.26892,61.16125,62.05357,62.94589,63.838218,64.63598,65.43374,66.2315,67.02926,67.827023,68.53711,69.24719,69.95728,70.66736,71.37745,72.00763,72.63781,73.26799,73.89817,74.528366,75.08665,75.64494,76.20323,76.76152,77.319809,77.814,78.30818,78.80237,79.29655,79.790727,80.2281,80.66548,81.10286,81.54024,81.977616,82.36485,82.75209,83.13933,83.52657,83.913812,84.16765,84.42149,84.67532,84.92916,85.183,85.49317,85.80334,86.1135,86.42367,,
Maldives,MDV,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,25.61622,26.26596,26.915697,27.84533,28.77497,29.7046,30.63423,31.563866,32.44839,33.33292,34.21744,35.10197,35.986495,36.60963,37.23276,37.8559,38.47903,39.102159,40.6649,42.22764,43.79038,45.35312,46.915865,48.28102,49.64619,51.01135,52.37651,53.741669,55.72576,57.70985,59.69395,61.67804,63.662138,65.26997,66.8778,68.48563,70.09347,71.701292,73.11891,74.53653,75.95415,77.37177,78.78939,80.32554,81.86169,83.39783,84.93398,86.47012,86.96134,87.45257,87.94379,88.43502,,
Mali,MLI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,18.23747,18.46082,18.684161,19.28174,19.87932,20.4769,21.07448,21.672062,22.58299,23.49393,24.40486,25.31579,26.226727,27.23699,28.24725,29.25751,30.26777,31.278022,32.39538,33.51274,34.6301,35.74746,36.864816,37.63555,38.40628,39.17701,39.94775,40.718483,41.23336,41.74825,42.26313,42.77801,43.292888,43.26799,43.2431,43.2182,43.19331,43.16841,43.79983,44.43124,45.06266,45.69408,46.325495,47.08788,47.85026,48.61264,49.37502,50.1374,50.74798,51.35857,51.96915,52.57973,,
Malta,MLT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,75.25188,75.83303,76.414174,76.93555,77.45694,77.97832,78.49971,79.021089,79.48736,79.95363,80.4199,80.88617,81.352429,81.76833,82.18424,82.60015,83.01606,83.431957,83.80219,84.17241,84.54263,84.91286,85.283094,85.61214,85.94118,86.27023,86.59928,86.928323,87.22042,87.51252,87.80462,88.09672,88.388808,88.64788,88.90695,89.16602,89.42509,89.684171,89.91382,90.14346,90.37311,90.60275,90.832401,91.03589,91.23938,91.44287,91.64636,91.849841,92.00246,92.15508,92.30769,92.46031,,
Marshall Islands,MHL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Mauritania,MRT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,37.43312,38.55128,39.669432,40.58634,41.50325,42.42015,43.33706,44.253968,45.0508,45.84763,46.64447,47.4413,48.23813,49.07255,49.90696,50.74138,51.57579,52.410212,53.27868,54.14714,55.0156,55.88406,56.752527,57.32063,57.88873,58.45684,59.02494,59.593044,59.97526,60.35748,60.7397,61.12191,61.504127,61.73257,61.96101,62.18945,62.41788,62.646317,62.83959,63.03287,63.22614,63.41942,63.6127,63.83814,64.06358,64.28902,64.51446,64.7399,65.00754,65.27518,65.54282,65.81046,,
Mauritius,MUS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,57.75772,59.41059,61.063464,61.94689,62.83032,63.71375,64.59718,65.480602,65.94963,66.41866,66.8877,67.35673,67.825752,68.77426,69.72277,70.67128,71.61979,72.568305,73.32681,74.0853,74.8438,75.6023,76.360819,76.51469,76.66857,76.82245,76.97633,77.13019,77.39074,77.65129,77.91184,78.17239,78.432951,78.71601,78.99907,79.28213,79.56519,79.848243,79.89059,79.93293,79.97527,80.01762,80.059957,80.52897,80.99798,81.46699,81.936,82.405,82.6335,82.862,83.0905,83.319,,
Mexico,MEX,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,57.40407,58.30949,59.214924,59.74381,60.2727,60.80159,61.33048,61.859374,62.61265,63.36592,64.1192,64.87247,65.62575,66.60196,67.57817,68.55438,69.53059,70.506802,71.29042,72.07404,72.85765,73.64127,74.424879,75.0122,75.59952,76.18684,76.77415,77.361486,77.89065,78.41981,78.94897,79.47813,80.007281,80.47861,80.94993,81.42125,81.89257,82.363899,82.72386,83.08382,83.44379,83.80375,84.163707,84.46421,84.76471,85.06521,85.36571,85.66622,85.89711,86.128,86.35889,86.58978,,
"Micronesia, Fed. Sts.",FSM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,55.67472,56.29219,56.909662,57.53896,58.16825,58.79755,59.42685,60.056145,60.72787,61.3996,62.07132,62.74305,63.414773,64.09649,64.77821,65.45992,66.14164,66.823344,67.00594,67.18853,67.37112,67.55372,67.736315,67.92365,68.11099,68.29833,68.48567,68.673019,68.85854,69.04405,69.22957,69.41508,69.600602,69.78735,69.97411,70.16086,70.34761,70.53436,70.73501,70.93566,71.13631,71.33697,71.537614,71.84512,72.15262,72.46012,72.76762,73.075123,73.32701,73.5789,73.83078,74.08266,,
Middle East & North Africa (all income levels),MEA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,44.316785616295796,45.1454681749682,45.9877169039206,46.8602476053432,47.7322844255213,48.596723950248006,49.449735084113506,50.3126199947843,51.102589908796794,51.896311080206395,52.6961844202854,53.496850866238205,54.2935381957386,55.2988260499393,56.2919249080476,57.275181535346206,58.251956524335,59.224432167488395,60.3816029936617,61.544602554905794,62.7121295600167,63.883402440283696,65.0597639600298,66.0794531367922,67.0952765324707,68.11234265590079,69.1260642587375,70.13704459529039,70.8346408350855,71.53245387557399,72.251569034101,72.970603874299,73.59823684268021,74.1783756274258,74.7537394709832,75.37595629500301,75.9386728748707,76.50162788328049,76.9070350275666,77.3147853205572,77.7241680516605,78.1339295378788,78.543268450439,78.89240906756609,79.2457823051853,79.6031056551078,79.9642475215915,80.3273126605906,80.6700902550932,81.00895073472908,81.3397143855631,81.6638149695907,,
Middle East & North Africa (developing only),MNA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,43.421809798847,44.2536915182307,45.0852572593018,45.9497760909647,46.811656200202705,47.670646894295594,48.526701297082006,49.380582735783605,50.1491724954096,50.9181628530212,51.6879049987103,52.459013465519895,53.2299543125785,54.210706871304396,55.1868549571888,56.1574368878033,57.1222877257675,58.0828540718203,59.2642972367107,60.4479960380746,61.635549644240506,62.8275718590026,64.023541869274,65.06903504099,66.1136068028263,67.1582960691839,68.2013620370062,69.2423797002885,69.9301526438131,70.620643819362,71.34076056587341,72.0465509944439,72.7498480375527,73.34083102635941,73.9275651840019,74.5096434624535,75.0889726522948,75.6673660823682,76.07728301673059,76.4882325871533,76.900379540963,77.31331919215499,77.72699524148729,78.079224048072,78.4342039424831,78.7909826573709,79.149215795947,79.5075879265512,79.85047957594091,80.18961908853349,80.5244554073915,80.8552014395263,,
Middle East and North Africa (IFC classification),CME,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Middle income,MIC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,41.999262066476604,42.714286341227,43.4084697870325,45.337752708832205,47.2739438826365,49.209474122559,51.1507676197101,53.0951512097015,54.2722716473505,55.4503832053397,56.6264024737463,57.8004603189863,58.964516653836405,59.747040854436904,60.530517013728705,61.315791985449295,62.1047760520891,62.8968802455588,63.5002324646774,64.1085976992852,64.7188792977406,65.3325775151237,65.9537675578604,66.4578562518127,66.956252194643,67.4525719327504,67.9489700889022,68.4453106882,68.8561787000805,69.2620777888721,69.6650194992695,70.0629098221808,70.4565658148379,70.80456099510559,71.15468623063559,71.50870498342529,71.8674723371964,72.23089427225909,72.6820564306148,73.13452753359341,73.5875202884491,74.0424241128195,74.5030439215767,74.9282033541374,75.3515576644594,75.7708816785384,76.18488565174592,76.59393591934399,76.9404533555752,77.2827406703274,77.6198027603809,77.9536875589881,,
Moldova,MDA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,67.21606,67.6833,68.150519,68.51178,68.87304,69.2343,69.59556,69.956808,70.03526,70.11372,70.19217,70.27062,70.349076,70.34908,70.34908,70.34908,70.34908,70.349076,70.16225,69.97542,69.78859,69.60176,69.414934,70.32079,71.22665,72.13251,73.03838,73.944245,74.01785,74.09145,74.16505,74.23865,74.312233,74.04626,73.78028,73.51431,73.24833,72.982336,73.25457,73.5268,73.79903,74.07127,74.343508,74.51264,74.68178,74.85091,75.02005,75.189175,75.44498,75.70078,75.95659,76.21239,,
Monaco,MCO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Mongolia,MNG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,47.92444,49.10678,50.289131,51.28988,52.29062,53.29136,54.29211,55.292847,56.08761,56.88237,57.67713,58.47189,59.266658,59.4227,59.57874,59.73478,59.89082,60.046854,60.20707,60.36729,60.52752,60.68774,60.847956,61.56453,62.2811,62.99767,63.71424,64.430821,64.29896,64.16709,64.03522,63.90336,63.771494,63.60414,63.43679,63.26944,63.10209,62.934738,64.06898,65.20322,66.33746,67.47169,68.605946,69.67323,70.74052,71.80782,72.87511,73.942389,74.36021,74.77804,75.19586,75.61369,,
Montenegro,MNE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,68.24727,69.16496,70.082639,71.12805,72.17346,73.21887,74.26428,75.309707,76.52888,77.74805,78.96722,80.18639,81.405573,81.86292,82.32027,82.77763,83.23498,83.692334,83.79729,83.90224,84.0072,84.11216,84.217106,84.41435,84.6116,84.80884,85.00608,85.203324,85.38346,85.56359,85.74372,85.92385,86.103991,86.26905,86.43411,86.59917,86.76424,86.929286,86.36927,85.80925,85.24923,84.68921,84.129202,84.24332,84.35743,84.47154,84.58566,84.699782,84.87292,85.04605,85.21918,85.39232,,
Morocco,MAR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,47.05011,47.34492,47.639738,48.2036,48.76746,49.33131,49.89517,50.459032,50.95734,51.45565,51.95395,52.45226,52.950572,53.55154,54.15251,54.75348,55.35444,55.955406,57.20795,58.46049,59.71304,60.96558,62.21813,63.27318,64.32822,65.38327,66.43832,67.493373,68.38845,69.28353,70.17861,71.07369,71.96877,72.42545,72.88213,73.33881,73.79549,74.252175,74.56287,74.87356,75.18425,75.49494,75.805622,76.07841,76.35119,76.62397,76.89675,77.169533,77.58701,78.00449,78.42197,78.83945,,
Mozambique,MOZ,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,26.64932,27.27583,27.902337,28.44061,28.97889,29.51716,30.05544,30.593715,31.20663,31.81955,32.43246,33.04538,33.658297,34.2468,34.8353,35.42381,36.01231,36.600817,36.72305,36.84528,36.96751,37.08974,37.211967,37.22185,37.23173,37.24161,37.25149,37.261373,37.65079,38.0402,38.42962,38.81903,39.208446,39.73621,40.26397,40.79174,41.3195,41.84726,41.51804,41.18881,40.85959,40.53036,40.201148,40.05796,39.91478,39.7716,39.62841,39.485231,39.774,40.06277,40.35155,40.64032,,
Myanmar,MMR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,37.70702,38.50405,39.301077,40.74941,42.19775,43.64609,45.09443,46.542756,47.17645,47.81013,48.44382,49.07751,49.711204,50.31554,50.91988,51.52421,52.12855,52.732888,53.31377,53.89465,54.47554,55.05642,55.637301,56.1969,56.7565,57.31609,57.87569,58.435295,58.98062,59.52595,60.07127,60.6166,61.16193,61.66316,62.16439,62.66563,63.16686,63.668083,64.13981,64.61153,65.08326,65.55499,66.026693,66.45502,66.88335,67.31168,67.74001,68.168358,68.48386,68.79935,69.11485,69.43035,,
Namibia,NAM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,42.44777,43.33307,44.218366,44.96556,45.71275,46.45993,47.20712,47.954317,48.7393,49.52428,50.30926,51.09424,51.879224,52.54241,53.2056,53.86879,54.53198,55.195166,56.15675,57.11832,58.0799,59.04148,60.003063,60.62135,61.23964,61.85792,62.47621,63.09449,63.05023,63.00597,62.96172,62.91746,62.873204,61.28321,59.69321,58.10321,56.51322,54.923214,52.57834,50.23346,47.88859,45.54371,43.198837,46.3167,49.43456,52.55243,55.67029,58.788148,60.32386,61.85957,63.39529,64.931,,
Nepal,NPL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,27.4891,28.08847,28.687843,29.26405,29.84025,30.41645,30.99265,31.568858,32.09009,32.61132,33.13256,33.65379,34.175025,34.93621,35.6974,36.45859,37.21978,37.980977,38.95354,39.92609,40.89865,41.87121,42.843771,43.92055,44.99733,46.0741,47.15088,48.22766,49.48933,50.75099,52.01266,53.27432,54.535988,55.69293,56.84987,58.00681,59.16375,60.320698,61.31667,62.31263,63.3086,64.30457,65.300537,66.15134,67.00215,67.85296,68.70377,69.554578,70.33688,71.11917,71.90147,72.68376,,
Netherlands,NLD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,84.31966,84.6166,84.913549,84.96956,85.02557,85.08159,85.1376,85.193607,85.36131,85.52902,85.69673,85.86444,86.032149,86.26392,86.49569,86.72746,86.95924,87.190999,87.37954,87.56808,87.75663,87.94518,88.13371,88.20857,88.28344,88.35831,88.43317,88.508033,88.56209,88.61614,88.6702,88.72425,88.778309,88.85315,88.92799,89.00282,89.07766,89.152492,89.23669,89.32088,89.40507,89.48926,89.573455,89.78165,89.98984,90.19803,90.40622,90.614396,90.7295,90.8446,90.95971,91.07481,,
New Caledonia,NCL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,55.67526,56.8803,58.085334,59.1705,60.25567,61.34084,62.426,63.511174,64.47106,65.43095,66.39083,67.35072,68.310594,69.16509,70.01959,70.87409,71.72859,72.583076,73.34498,74.10688,74.86878,75.63068,76.39259,77.05283,77.71306,78.37329,79.03352,79.693758,80.24142,80.78909,81.33675,81.88441,82.432074,82.86883,83.30558,83.74233,84.17908,84.615829,84.96888,85.32193,85.67498,86.02803,86.381085,86.66072,86.94035,87.21999,87.49962,87.779247,88.01661,88.25397,88.49134,88.72871,,
New Zealand,NZL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,80.0022,80.27569,80.549192,80.5526,80.55602,80.55943,80.56284,80.566253,80.68804,80.80983,80.93162,81.05341,81.17519,81.38248,81.58978,81.79708,82.00438,82.211667,82.5035,82.79533,83.08717,83.379,83.67083,83.85633,84.04183,84.22733,84.41283,84.598341,84.9742,85.35005,85.72591,86.10176,86.477614,86.72652,86.97544,87.22436,87.47327,87.72218,88.048,88.37383,88.69965,89.02547,89.351294,89.58204,89.81278,90.04353,90.27427,90.505019,90.62435,90.74369,90.86303,90.98237,,
Nicaragua,NIC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,42.0928,43.03241,43.972,44.991,46.01,47.029,48.048,49.067,50.0948,51.1226,52.1504,53.1782,54.206,55.233,56.26,57.287,58.314,59.341,60.0988,60.8566,61.6144,62.3722,63.13,63.9966,64.8632,65.7298,66.5964,67.463,68.1172,68.7714,69.4256,70.0798,70.734,71.3086,71.8832,72.4578,73.0324,73.607,74.315,75.023,75.731,76.439,77.147,77.7684,78.3898,79.0112,79.6326,80.254,80.67657,81.09914,81.52171,81.94428,,
Niger,NER,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,25.56749,25.73647,25.905442,26.03516,26.16488,26.2946,26.42432,26.554046,26.86005,27.16606,27.47207,27.77808,28.084084,28.63599,29.1879,29.73981,30.29172,30.843622,31.71801,32.5924,33.46678,34.34117,35.215553,36.08475,36.95396,37.82316,38.69236,39.561555,40.33699,41.11242,41.88785,42.66328,43.438712,44.10025,44.76179,45.42332,46.08486,46.746398,47.45447,48.16254,48.87062,49.57869,50.286765,51.11366,51.94056,52.76746,53.59436,54.421263,55.16317,55.90508,56.64699,57.3889,,
Nigeria,NGA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,29.37046,29.97319,30.575917,31.06263,31.54935,32.03606,32.52277,33.009488,33.56762,34.12575,34.68388,35.24202,35.800142,36.42935,37.05856,37.68776,38.31697,38.946173,39.43908,39.93198,40.42489,40.91779,41.410696,41.3876,41.3645,41.3414,41.3183,41.2952,41.27499,41.25477,41.23456,41.21434,41.194134,40.98476,40.77539,40.56602,40.35666,40.147291,40.10671,40.06613,40.02555,39.98497,39.94438,40.65753,41.37068,42.08383,42.79698,43.510137,44.13768,44.76523,45.39277,46.02032,,
North America,NAC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.4300548066104,78.60270598062779,78.7755576756539,78.9133019638524,79.0513767965231,79.18980288228751,79.32876567710392,79.46795405620941,79.7065848943939,79.94473969829009,80.1826571962824,80.4207197700831,80.65962749309159,81.10386395118309,81.5479262696208,81.9914280243946,82.43321851166091,82.8742428067232,83.13652399614931,83.3987227601387,83.661971252562,83.9252728658603,84.1887217523824,84.32804343301359,84.46743681593009,84.6066848878734,84.7460057450205,84.88626791825659,85.05441704417409,85.2238877346455,85.3920242374643,85.55916767637392,85.7257304287897,85.8671303126262,86.00835200848141,86.14920989335009,86.29083377958771,86.43221127911809,86.5587204845404,86.6851295671829,86.8117958201961,86.93921211858351,87.066449950908,87.2150741272747,87.36357643769631,87.512133595112,87.660144702265,87.8090816866587,87.94062174993348,88.07238238845699,88.2039496151999,88.33520723872792,,
Northern Mariana Islands,MNP,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Norway,NOR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,84.93558,85.10548,85.275383,85.42687,85.57836,85.72985,85.88134,86.032846,86.26008,86.48731,86.71455,86.94178,87.169013,87.28868,87.40836,87.52803,87.64771,87.767371,87.92359,88.07981,88.23603,88.39225,88.548461,88.45166,88.35486,88.25806,88.16125,88.064469,88.25818,88.45189,88.6456,88.83931,89.033032,89.21818,89.40333,89.58848,89.77363,89.95877,90.06981,90.18085,90.29189,90.40292,90.513953,90.70548,90.89701,91.08854,91.28007,91.471601,91.58367,91.69574,91.80781,91.91988,,
Not classified,INX,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
OECD members,OED,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,75.7733829649069,76.262248470679,76.75644116002809,77.09893233802809,77.4398629114236,77.7764624985007,78.1070714028385,78.4326706495603,78.75993466253409,79.0959738178699,79.4301894974501,79.76892088626221,80.11190595823359,80.52413956208629,80.9454142776691,81.3676112120816,81.7887859370992,82.2157111896105,82.55341102531791,82.8936113765793,83.23650931172071,83.582531546491,83.9302896166186,84.19411442848009,84.4600804687465,84.7284702555045,84.9992082499291,85.271467985499,85.5082133101,85.7472439193876,85.9859686209869,86.22384271638441,86.46242437001841,86.6948743127337,86.92986658232809,87.16802158858971,87.40883589626159,87.6519909537354,87.8667910174594,88.08296635297951,88.30118055998828,88.5212649995016,88.74263424376561,88.9342981513817,89.1261892452241,89.3190035606248,89.51323683552,89.70969087536601,89.8584306379936,90.00601671854321,90.1529934745615,90.30184226736479,,
Oman,OMN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,38.50418,39.59252,40.680844,41.72512,42.76939,43.81366,44.85793,45.9022,46.92835,47.9545,48.98065,50.0068,51.032955,52.55777,54.08259,55.60741,57.13223,58.657052,60.04537,61.43368,62.82199,64.21031,65.598626,66.74687,67.89512,69.04337,70.19161,71.339869,72.24689,73.15392,74.06095,74.96798,75.875011,76.63254,77.39006,78.14758,78.90511,79.662637,80.28143,80.90023,81.51903,82.13783,82.756632,83.25779,83.75895,84.26011,84.76127,85.262435,85.57504,85.88763,86.20023,86.51283,,
Other small states,OSS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,40.220600597452396,40.8997374501069,41.581237876351,42.1993837068142,42.8210859596501,43.4475097422387,44.07947782482671,44.7169190147426,45.4944860162169,46.277035363269206,47.0643949274147,47.855800297164095,48.65080847301889,49.27937835817529,49.91699063656571,50.569727452471106,51.2455227602048,51.9451307808644,52.9516724089071,53.9275181104109,54.86303598679171,55.757579685322,56.6204954622128,57.261906969821204,57.8930628784548,58.521626034832,59.1547765969477,59.787956969937895,60.0308395067945,60.2787381599026,60.5379500193748,60.808441298910395,61.0893947812681,60.20122066561629,59.3055603046365,58.3834603045368,57.444690343906096,56.489789638937594,55.318474427187006,54.148583718724005,52.984522088080794,51.853961630019704,50.7657070826031,51.457491851771,52.147651764093,52.821842426156394,53.5019925666634,54.1756351937772,54.7816940465174,55.3843812420018,55.99500778044,56.6020518712557,,
Pacific island small states,PSS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,51.169109522656896,51.8452860502328,52.5334612067934,53.207639154050206,53.8763627631538,54.53484046307779,55.181997604235896,55.82075983721371,56.442881287200095,57.0638200788372,57.6848149864569,58.3061552123182,58.925722666561605,59.5109461564158,60.0891820431145,60.66053724564421,61.226115717010096,61.788498964544,62.2703227448071,62.751395774789295,63.232731300469595,63.714788937783794,64.1962946957453,64.4419341538656,64.6767192147292,64.89616322610479,65.0964409960783,65.27701753017489,65.7136828364109,66.1548303621856,66.6045689289205,67.0635366184595,67.5297763447265,68.0223519333573,68.51841429086329,69.0165241369659,69.5165234665662,70.0195349048401,70.5524673878128,71.09308246404859,71.6422622992143,72.20022595940809,72.7667936392819,73.22899836640671,73.69417331810591,74.16173332582129,74.6314940664472,75.10325162627,75.50344140565859,75.90445131018821,76.3060314413183,76.7081120059727,,
Pakistan,PAK,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,40.5386,41.76709,42.995566,44.01909,45.04261,46.06614,47.08966,48.113187,48.9372,49.76121,50.58522,51.40924,52.233245,53.07364,53.91404,54.75444,55.59483,56.435235,57.04393,57.65262,58.26131,58.87,59.478693,60.01168,60.54468,61.07767,61.61066,62.143656,62.59527,63.04688,63.49849,63.9501,64.401712,64.7747,65.14768,65.52067,65.89365,66.26665,66.63731,67.00797,67.37863,67.74929,68.119956,68.44001,68.76006,69.08012,69.40017,69.720211,69.99325,70.26628,70.53931,70.81235,,
Palau,PLW,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Panama,PAN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,61.62892,62.56502,63.50112,64.29063,65.08013,65.86964,66.65914,67.44866,68.29287,69.13708,69.98129,70.82549,71.6697,72.45287,73.23603,74.0192,74.80236,75.58554,76.24289,76.90024,77.55759,78.21494,78.8723,79.42907,79.98584,80.54261,81.09938,81.65616,81.96214,82.2681,82.57407,82.88004,83.18602,83.35983,83.53365,83.70746,83.88127,84.05509,84.21985,84.38461,84.54936,84.71412,84.87888,85.01335,85.14783,85.2823,85.41678,85.55125,85.73805,85.92485,86.11165,86.29845,,
Papua New Guinea,PNG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,22.43832,23.14794,23.85756,25.00315,26.14873,27.29432,28.43991,29.585493,30.62734,31.66918,32.71103,33.75287,34.794714,35.9229,37.05109,38.17928,39.30747,40.435655,42.21355,43.99145,45.76934,47.54724,49.325133,49.37438,49.42363,49.47288,49.52213,49.571374,50.26129,50.95121,51.64113,52.33105,53.020959,53.32727,53.63358,53.9399,54.24621,54.552524,55.0579,55.56327,56.06865,56.57402,57.079397,57.76982,58.46024,59.15067,59.84109,60.531511,60.83829,61.14507,61.45185,61.75864,,
Paraguay,PRY,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,69.5066,69.8528,70.199,70.381,70.563,70.745,70.92699,71.109,71.3844,71.6598,71.9352,72.21059,72.486,72.599,72.712,72.825,72.938,73.051,73.1578,73.2646,73.37139,73.47819,73.585,73.686,73.78699,73.88799,73.98899,74.09,74.2442,74.3984,74.5526,74.70679,74.861,75.0126,75.16421,75.31581,75.46741,75.619,75.8312,76.0434,76.25559,76.46779,76.68,76.9594,77.2388,77.5182,77.79761,78.077,78.24,78.403,78.566,78.729,,
Peru,PER,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,46.67464,47.54095,48.407248,49.1447,49.88216,50.61961,51.35706,52.094522,53.37156,54.64859,55.92563,57.20266,58.479701,59.44791,60.41613,61.38434,62.35255,63.320765,64.09566,64.87057,65.64547,66.42037,67.195258,67.86832,68.54139,69.21445,69.88752,70.560583,71.11487,71.66915,72.22343,72.77772,73.332,74.0424,74.7528,75.4632,76.17361,76.884,77.5302,78.1764,78.8226,79.4688,80.115,80.4976,80.8802,81.26279,81.64539,82.028,82.39956,82.77112,83.14268,83.51424,,
Philippines,PHL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,57.19392,57.61581,58.037706,58.54109,59.04448,59.54786,60.05124,60.554629,61.0325,61.51037,61.98824,62.46611,62.943989,63.20376,63.46352,63.72329,63.98306,64.242826,64.67463,65.10643,65.53823,65.97003,66.401825,66.9398,67.47778,68.01576,68.55374,69.091717,69.44167,69.79163,70.14159,70.49155,70.841509,71.16545,71.4894,71.81334,72.13728,72.461225,72.76134,73.06146,73.36158,73.6617,73.961828,74.24018,74.51853,74.79688,75.07523,75.35358,75.67117,75.98876,76.30635,76.62394,,
Poland,POL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.0592,77.01104,77.962887,78.44919,78.93549,79.42178,79.90808,80.394389,80.69165,80.98891,81.28618,81.58344,81.880712,81.97328,82.06586,82.15843,82.25101,82.343573,82.36015,82.37674,82.39333,82.40991,82.426493,82.4589,82.4913,82.5237,82.55611,82.588516,82.73616,82.8838,83.03145,83.17909,83.326749,83.70967,84.09259,84.47551,84.85843,85.241353,85.57877,85.91619,86.25361,86.59103,86.928443,87.22227,87.51611,87.80994,88.10377,88.397615,88.54045,88.68329,88.82613,88.96896,,
Portugal,PRT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,71.95333,72.67651,73.399677,73.9929,74.58611,75.17933,75.77254,76.365775,76.90989,77.454,77.99812,78.54223,79.086353,79.64275,80.19913,80.75552,81.31191,81.868315,82.40062,82.93292,83.46523,83.99753,84.529824,84.87143,85.21304,85.55464,85.89625,86.237861,86.47798,86.7181,86.95822,87.19834,87.438469,87.72353,88.0086,88.29366,88.57873,88.863778,89.13295,89.40212,89.6713,89.94047,90.209648,90.48341,90.75718,91.03094,91.30471,91.57846,91.72861,91.87875,92.0289,92.17905,,
Puerto Rico,PRI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.14191,76.6589,77.175881,77.71105,78.24622,78.78139,79.31657,79.851727,80.36279,80.87385,81.38491,81.89597,82.40703,82.64177,82.87651,83.11125,83.34599,83.580717,83.67986,83.77901,83.87815,83.97729,84.076429,84.42492,84.77341,85.12191,85.47041,85.818891,85.90158,85.98427,86.06696,86.14964,86.232335,86.37032,86.50829,86.64627,86.78425,86.922239,87.22263,87.52302,87.82341,88.1238,88.424182,88.60795,88.79172,88.97549,89.15926,89.343022,89.46162,89.58022,89.69882,89.81742,,
Qatar,QAT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,66.06278,66.95264,67.84249,68.69133,69.54017,70.38901,71.23785,72.086687,72.77505,73.46342,74.15179,74.84016,75.528525,75.99363,76.45873,76.92384,77.38894,77.854033,78.23994,78.62584,79.01174,79.39764,79.78356,80.10892,80.43427,80.75963,81.08498,81.410334,81.69798,81.98563,82.27327,82.56091,82.848567,83.14101,83.43345,83.72589,84.01833,84.310774,84.63642,84.96207,85.28771,85.61336,85.939011,86.28014,86.62126,86.96239,87.30351,87.644639,87.81464,87.98465,88.15466,88.32466,,
Romania,ROM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,73.3784,74.87787,76.377342,76.39249,76.40763,76.42278,76.43792,76.45307,76.87832,77.30357,77.72883,78.15408,78.579329,78.74554,78.91174,79.07795,79.24416,79.410375,79.49354,79.57671,79.65987,79.74304,79.826204,79.79626,79.76631,79.73637,79.70642,79.67646,79.78291,79.88935,79.9958,80.10224,80.2087,80.22498,80.24127,80.25756,80.27385,80.290129,80.72079,81.15145,81.58212,82.01278,82.443438,82.89373,83.34402,83.79432,84.24461,84.694894,84.869,85.04311,85.21722,85.39133,,
Russian Federation,RUS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.14827,77.03498,77.921695,78.22916,78.53661,78.84407,79.15153,79.458994,79.50154,79.54409,79.58664,79.62919,79.67173,79.43012,79.18851,78.94691,78.7053,78.463698,78.41982,78.37593,78.33205,78.28816,78.244286,78.66908,79.09388,79.51868,79.94347,80.368284,79.80579,79.24329,78.6808,78.11831,77.555807,77.33921,77.12261,76.90601,76.68941,76.472828,76.1879,75.90298,75.61806,75.33315,75.048224,75.6006,76.15298,76.70535,77.25773,77.8101,78.04246,78.27482,78.50718,78.73954,,
Rwanda,RWA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,36.44391,36.85879,37.273666,37.58611,37.89854,38.21098,38.52342,38.835867,38.97128,39.10668,39.24209,39.37749,39.512901,39.81965,40.1264,40.43314,40.73989,41.046638,41.98742,42.92821,43.86899,44.80978,45.750569,44.39588,43.04119,41.68651,40.33182,38.977136,33.68302,28.38891,23.0948,17.80068,12.506568,16.70908,20.91159,25.1141,29.31661,33.519125,35.24387,36.96861,38.69336,40.4181,42.142845,45.60993,49.07701,52.54409,56.01118,59.478258,60.93771,62.39717,63.85662,65.31608,,
Samoa,WSM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,42.72031,43.5527,44.385097,45.24683,46.10856,46.97029,47.83203,48.693757,49.58075,50.46773,51.35472,52.2417,53.128691,54.03586,54.94304,55.85021,56.75738,57.664548,58.58518,59.50582,60.42645,61.34709,62.267718,63.19294,64.11816,65.04339,65.96861,66.893823,67.84985,68.80589,69.76192,70.71795,71.673963,72.46494,73.25592,74.0469,74.83788,75.628844,76.19577,76.7627,77.32962,77.89655,78.463466,78.90267,79.34188,79.78109,80.2203,80.659497,81.11849,81.57748,82.03648,82.49547,,
San Marino,SMR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Sao Tome and Principe,STP,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,47.9716,48.81448,49.657347,50.38309,51.10883,51.83456,52.5603,53.286044,54.04406,54.80207,55.56009,56.3181,57.076118,57.96468,58.85323,59.74179,60.63035,61.518901,61.8101,62.10129,62.39249,62.68368,62.974885,63.2215,63.46812,63.71473,63.96135,64.207967,64.45431,64.70065,64.947,65.19334,65.439688,65.68164,65.92359,66.16554,66.40749,66.649443,66.88804,67.12663,67.36523,67.60382,67.842427,68.38592,68.92941,69.47289,70.01638,70.559862,70.82031,71.08076,71.3412,71.60165,,
Saudi Arabia,SAU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,43.24241,43.89179,44.541163,45.40833,46.27549,47.14265,48.00982,48.876983,50.35194,51.82689,53.30184,54.77679,56.251748,57.82734,59.40294,60.97853,62.55412,64.129716,65.35684,66.58397,67.8111,69.03822,70.26534,71.14398,72.02262,72.90126,73.7799,74.658536,75.72092,76.78332,77.84571,78.9081,79.970484,80.41605,80.86161,81.30717,81.75274,82.198296,82.55969,82.92109,83.28249,83.64388,84.005263,84.30096,84.59665,84.89234,85.18803,85.483715,85.76118,86.03866,86.31613,86.59361,,
Senegal,SEN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,29.93868,30.29894,30.659196,30.66429,30.66938,30.67447,30.67957,30.684663,31.44606,32.20746,32.96886,33.73026,34.491646,36.17306,37.85448,39.53589,41.21731,42.898725,44.38968,45.88064,47.3716,48.86256,50.353521,51.89179,53.43005,54.96832,56.50658,58.044854,58.52171,58.99857,59.47542,59.95228,60.429127,60.26194,60.09476,59.92757,59.76038,59.593202,59.99838,60.40356,60.80873,61.21391,61.619084,62.4523,63.28553,64.11874,64.95197,65.785185,66.13715,66.48911,66.84106,67.19302,,
Serbia,SRB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,67.38852,68.27151,69.154506,70.14819,71.14188,72.13556,73.12924,74.122924,74.67236,75.22181,75.77126,76.3207,76.870139,77.27501,77.67988,78.08475,78.48962,78.894484,79.07188,79.24929,79.4267,79.6041,79.781503,80.11048,80.43946,80.76844,81.09742,81.426395,81.59826,81.77012,81.94198,82.11384,82.2857,82.333,82.3803,82.4276,82.47491,82.522199,82.67625,82.83031,82.98436,83.13841,83.29247,83.54005,83.78764,84.03522,84.2828,84.530395,84.72526,84.92012,85.11498,85.30984,,
Seychelles,SYC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,63.61708,65.13297,66.648863,67.28609,67.92331,68.56053,69.19775,69.83497,70.6613,71.48763,72.31396,73.1403,73.966638,74.68256,75.39848,76.1144,76.83031,77.546237,78.03039,78.51454,78.9987,79.48285,79.966997,80.23737,80.50774,80.77811,81.04848,81.318842,81.50832,81.69779,81.88727,82.07674,82.266227,82.43501,82.6038,82.77258,82.94137,83.110138,83.2621,83.41406,83.56602,83.71799,83.869938,84.01445,84.15897,84.30348,84.448,84.592508,84.7864,84.98029,85.17419,85.36808,,
Sierra Leone,SLE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,21.00313,21.21687,21.430619,21.77349,22.11635,22.45922,22.80209,23.144953,23.7254,24.30584,24.88629,25.46673,26.047179,26.86479,27.68241,28.50002,29.31764,30.135256,30.3087,30.48214,30.65558,30.82902,31.002462,30.37526,29.74806,29.12085,28.49365,27.866449,27.07266,26.27888,25.4851,24.69131,23.897529,23.93632,23.97512,24.01391,24.0527,24.091497,25.07825,26.06501,27.05176,28.03852,29.025271,30.09873,31.17218,32.24564,33.31909,34.392544,34.77253,35.15251,35.53249,35.91247,,
Singapore,SGP,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,71.30139,71.92019,72.539,73.13255,73.72609,74.31963,74.91318,75.506725,75.90975,76.31277,76.7158,77.11882,77.521848,78.07828,78.6347,79.19113,79.74756,80.304,80.80591,81.30782,81.80972,82.31163,82.813528,83.17934,83.54517,83.91099,84.27681,84.642627,85.13316,85.62368,86.1142,86.60473,87.095261,87.4244,87.75354,88.08268,88.41182,88.740964,89.21508,89.68919,90.16331,90.63742,91.111547,91.35058,91.58961,91.82864,92.06767,92.306697,92.47139,92.63608,92.80077,92.96545,,
Sint Maarten (Dutch part),SXM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Slovak Republic,SVK,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,79.50622,80.23016,80.954106,80.99995,81.04578,81.09162,81.13746,81.183307,81.18838,81.19345,81.19852,81.2036,81.208671,81.34992,81.49117,81.63242,81.77367,81.914913,81.99074,82.06656,82.14238,82.2182,82.294031,82.39036,82.48669,82.58302,82.67934,82.77568,82.98981,83.20395,83.41808,83.63222,83.846345,84.14817,84.45,84.75182,85.05365,85.355486,85.6349,85.91432,86.19374,86.47316,86.752589,86.91335,87.07412,87.23489,87.39565,87.556413,87.69566,87.83491,87.97415,88.1134,,
Slovenia,SVN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,75.93385,76.5238,77.113739,77.34592,77.57809,77.81027,78.04245,78.274646,78.61774,78.96085,79.30395,79.64705,79.990142,80.47237,80.95461,81.43684,81.91907,82.401294,82.54279,82.68428,82.82578,82.96727,83.108768,83.49138,83.87399,84.25661,84.63922,85.02183,85.24445,85.46707,85.68969,85.91231,86.134933,86.45912,86.78331,87.1075,87.43169,87.755877,88.04153,88.32719,88.61285,88.89851,89.184159,89.56065,89.93715,90.31364,90.69014,91.066631,91.19118,91.31574,91.4403,91.56486,,
Small states,SST,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,49.727437627330396,50.4152087597507,51.115818919040606,51.665919332906,52.2029448440901,52.7189951443876,53.21328059064079,53.6922074920461,54.2414695532613,54.8108420475712,55.411593439177196,56.0433173226398,56.7005419284773,57.239991518976495,57.7921282460903,58.3542890110222,58.9310150572186,59.521563656020696,60.25090435023971,60.9585950228792,61.638192817637204,62.285579539421796,62.91475723860621,63.35814482621161,63.7866026147493,64.2009857618305,64.6066373014536,65.00191744542629,65.1527569109006,65.3179849668154,65.4926329194991,65.6805533863105,65.8802555076779,65.3571886199965,64.8267387100917,64.27813499747579,63.72076957220511,63.144974628228205,62.4532686071888,61.75531735684879,61.0592881510572,60.383989908865395,59.7331785392394,60.246610025234496,60.7641619305905,61.2745474881053,61.78290946537889,62.2871246367083,62.7378338386926,63.186493043737,63.640134103346995,64.0947921177541,,
Solomon Islands,SLB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,43.92238,44.63214,45.341896,46.06264,46.78339,47.50414,48.22489,48.945632,49.69255,50.43947,51.18639,51.9333,52.680221,53.44818,54.21613,54.98409,55.75204,56.520005,56.71682,56.91364,57.11045,57.30727,57.504083,56.50598,55.50787,54.50977,53.51167,52.513561,53.28996,54.06636,54.84275,55.61915,56.395552,57.39886,58.40217,59.40548,60.40879,61.412105,62.70643,64.00075,65.29507,66.58939,67.883717,68.46719,69.05066,69.63413,70.21761,70.801077,71.23026,71.65945,72.08863,72.51781,,
Somalia,SOM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,29.39274,29.91091,30.42907,30.96675,31.50443,32.0421,32.57978,33.117459,33.63626,34.15507,34.67388,35.19268,35.711486,36.2285,36.74551,37.26252,37.77953,38.296544,38.76729,39.23804,39.70879,40.17954,40.650279,40.88464,41.11901,41.35337,41.58773,41.822094,41.39723,40.97237,40.54751,40.12265,39.697775,41.01587,42.33395,43.65204,44.97013,46.288221,46.73828,47.18834,47.6384,48.08847,48.538525,49.02724,49.51596,50.00467,50.49339,50.982109,51.45971,51.93732,52.41492,52.89252,,
South Africa,ZAF,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,38.46268,39.26131,40.059934,40.89447,41.72901,42.56355,43.39809,44.232629,44.95035,45.66806,46.38578,47.1035,47.821218,48.60712,49.39301,50.17891,50.96481,51.750707,52.89688,54.04305,55.18922,56.33539,57.481563,58.53405,59.58653,60.63901,61.69149,62.743979,63.1407,63.53743,63.93415,64.33087,64.727598,63.09337,61.45914,59.82491,58.19069,56.556459,53.20443,49.8524,46.50037,43.14835,39.79632,39.47275,39.14919,38.82562,38.50205,38.178487,40.33363,42.48877,44.64391,46.79905,,
South Asia,SAS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,30.5088064206699,31.487763185305198,32.4659419911645,33.6204695503402,34.7808944532401,35.934358783410204,37.0848226053366,38.2314330835445,39.3087335690199,40.380808217403896,41.4512293294767,42.5187755513838,43.588895250084896,44.937018837955506,46.283240027831496,47.6296966634213,48.9760801368898,50.3227107065946,51.017321694274905,51.715132460881,52.415349319287,53.11311928362571,53.819674785881006,54.3536930035965,54.8851586937496,55.415523615980796,55.9448958738464,56.4714706663046,57.0908078594489,57.7062870076536,58.316993539094106,58.925012162863105,59.528376724801205,60.2018868608463,60.877610786379,61.5566213531426,62.238531231192,62.92369654637049,63.6400769582949,64.35647475321649,65.0673614491922,65.7704020331886,66.4778608217811,67.1310599486763,67.7838142746884,68.4357803502886,69.0878778986502,69.7394308374159,70.1818647712852,70.6246329166765,71.0666754122772,71.50853954270059,,
South Asia (IFC classification),CSA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
South Sudan,SSD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,22.54038,23.05647,23.572555,24.11049,24.64843,25.18637,25.72431,26.262254,26.73769,27.21313,27.68857,28.164,28.639444,29.17092,29.70239,30.23386,30.76534,31.296812,31.4867,31.67658,31.86647,32.05636,32.246246,32.88272,33.51919,34.15567,34.79214,35.42861,36.36615,37.30368,38.24121,39.17875,40.116291,40.7781,41.4399,42.1017,42.76351,43.425319,43.73838,44.05144,44.3645,44.67756,44.990623,45.33876,45.6869,46.03503,46.38317,46.731301,47.63351,48.53572,49.43792,50.34013,,
Spain,ESP,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.1166,78.82557,79.53454,80.01764,80.50074,80.98384,81.46694,81.95003,82.36672,82.78341,83.2001,83.61678,84.03348,84.49174,84.95,85.40826,85.86652,86.32477,86.78856,87.25235,87.71614,88.17993,88.64373,88.85168,89.05964,89.26759,89.47555,89.6835,89.85325,90.02299,90.19274,90.36249,90.53225,90.744,90.95574,91.16749,91.37923,91.59099,91.76497,91.93895,92.11293,92.28691,92.4609,92.72131,92.98172,93.24213,93.50253,93.76295,93.86504,93.96714,94.06924,94.17133,,
Sri Lanka,LKA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,64.25211,64.80983,65.367561,66.08869,66.80982,67.53095,68.25208,68.973208,69.41553,69.85785,70.30017,70.74249,71.184803,71.67289,72.16097,72.64906,73.13714,73.625236,74.54915,75.47306,76.39697,77.32088,78.244812,78.38668,78.52855,78.67042,78.81229,78.954146,79.2262,79.49825,79.77029,80.04234,80.3144,80.22077,80.12714,80.03352,79.93989,79.846266,80.94733,82.0484,83.14947,84.25053,85.351613,85.3905,85.42938,85.46827,85.50716,85.546039,85.74345,85.94085,86.13825,86.33566,,
St. Kitts and Nevis,KNA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
St. Lucia,LCA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,60.53653,61.40069,62.26485,62.46582,62.66678,62.86775,63.06871,63.26968,64.22163,65.17359,66.12555,67.07751,68.02945,68.91972,69.80998,70.70025,71.59052,72.48078,73.32585,74.17093,75.01601,75.86108,76.70615,76.66641,76.62667,76.58693,76.54719,76.50745,76.49455,76.48165,76.46875,76.45585,76.44295,76.22221,76.00146,75.78072,75.55998,75.33923,75.73953,76.13983,76.54013,76.94043,77.34074,78.11983,78.89893,79.67803,80.45713,81.23622,81.42609,81.61595,81.80582,81.99568,,
St. Martin (French part),MAF,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
St. Vincent and the Grenadines,VCT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,63.60435,65.38551,67.16668,67.8457,68.52473,69.20375,69.88277,70.5618,70.92215,71.2825,71.64285,72.0032,72.36356,72.50241,72.64126,72.78011,72.91895,73.0578,73.49165,73.92551,74.35936,74.79321,75.22705,75.41767,75.60829,75.79891,75.98953,76.18016,76.10792,76.03568,75.96343,75.89119,75.81896,75.83917,75.85938,75.87959,75.8998,75.92002,76.12852,76.33703,76.54553,76.75404,76.96253,77.24601,77.52949,77.81297,78.09644,78.37992,78.60403,78.82813,79.05224,79.27634,,
Sub-Saharan Africa (all income levels),SSF,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,32.9233184510697,33.5440089160524,34.1645386360712,34.7206831247127,35.2771636207357,35.8343462768225,36.392420646676605,36.951445502072396,37.5598750491801,38.1688472740679,38.7783577835832,39.389546685278,40.00146718143571,40.60221984133779,41.2003951271589,41.795347839590995,42.3867573062075,42.97553430303579,43.46789260200929,43.9633211434367,44.4636409348141,44.968646006856204,45.4771795833073,45.7791158638066,46.0824076300352,46.385798232943706,46.6883487571346,46.9893607235259,46.91127607484199,46.830772760529,46.7535114624874,46.68882960679421,46.6389631126959,46.315455131743896,45.975285323204496,45.6173878591544,45.247445351876,44.872656353486,44.7493438546519,44.624498563898,44.5011260665671,44.382085289985895,44.27290137079329,45.1931174486601,46.117206060227794,47.0445705420776,47.975652157628204,48.9103768302924,50.045704172731504,51.175026854792605,52.2982012110727,53.4197502552493,,
Sub-Saharan Africa (developing only),SSA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,32.9279994920037,33.548900110233895,34.169627462156804,34.7258818708656,35.282487598501,35.8398188497524,36.3980791336761,36.957316210520396,37.565981197929794,38.17509776503879,38.7846129116782,39.395646542464206,40.0072750918265,40.607640214463295,41.2054237537559,41.8000443657631,42.3911915144884,42.9797725070234,43.4719064733916,43.967248389474605,44.467623538307,44.972832397137296,45.4816873707875,45.7838881929941,46.087381768674895,46.3908603578324,46.6933796658107,46.99427080932139,46.9157499840044,46.8347968585703,46.757100781095104,46.692007167403794,46.6417490180115,46.3179184852048,45.9774248450202,45.619201312015896,45.2489326378805,44.873819971063206,44.75047549601211,44.625600139408,44.502201126126096,44.3831396735784,44.2739447795497,45.194409839263,46.118756555109904,47.0463859476912,47.97773813318379,48.9127382815265,50.0482945615319,51.1778421460869,52.3012365551184,53.423005098139896,,
Sub-Saharan Africa (IFC classification),CAA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Sudan,SDN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,44.54148,45.14257,45.743669,46.30777,46.87187,47.43597,48.00008,48.564182,49.07762,49.59106,50.1045,50.61794,51.131375,51.40886,51.68635,51.96384,52.24133,52.518815,52.65213,52.78544,52.91875,53.05206,53.185372,53.39065,53.59592,53.8012,54.00648,54.211756,54.49733,54.78291,55.06848,55.35406,55.639633,56.06718,56.49473,56.92228,57.34982,57.777375,58.3017,58.82603,59.35036,59.87469,60.399025,60.9545,61.50998,62.06546,62.62093,63.176404,63.51368,63.85096,64.18824,64.52552,,
Suriname,SUR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,59.82579,60.43228,61.03877,61.7046,62.37043,63.03625,63.70208,64.36791,65.05605,65.74419,66.43233,67.12048,67.80863,68.20846,68.60828,69.00811,69.40794,69.80777,70.46485,71.12193,71.77901,72.4361,73.09319,73.36268,73.63217,73.90166,74.17116,74.44065,74.52442,74.60819,74.69196,74.77573,74.8595,74.89775,74.936,74.97424,75.01249,75.05074,75.10281,75.15487,75.20693,75.259,75.31107,75.812,76.31294,76.81388,77.31482,77.81575,78.16116,78.50658,78.85199,79.1974,,
Swaziland,SWZ,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,38.238,38.68119,39.124384,39.58039,40.0364,40.49241,40.94842,41.404426,42.23492,43.06542,43.89592,44.72642,45.556915,46.40449,47.25207,48.09964,48.94722,49.794797,50.83028,51.86577,52.90125,53.93674,54.972228,55.66148,56.35072,57.03997,57.72922,58.418461,58.51252,58.60659,58.70065,58.79471,58.888773,56.63639,54.38401,52.13163,49.87925,47.62688,44.80174,41.9766,39.15145,36.32631,33.501178,33.51999,33.53881,33.55762,33.57644,33.595256,33.60869,33.62213,33.63556,33.649,,
Sweden,SWE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,83.78391,84.08882,84.39373,84.62836,84.86298,85.09761,85.33224,85.566866,85.75733,85.9478,86.13827,86.32874,86.519204,86.68134,86.84348,87.00562,87.16776,87.329897,87.53246,87.73502,87.93758,88.14014,88.342713,88.48729,88.63187,88.77644,88.92102,89.065591,89.18394,89.30228,89.42063,89.53898,89.657314,89.86068,90.06404,90.2674,90.47076,90.674133,90.78893,90.90372,91.01851,91.1333,91.248082,91.40219,91.5563,91.7104,91.86451,92.018616,92.13215,92.24568,92.35921,92.47275,,
Switzerland,CHE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,81.88559,82.29772,82.709862,83.006,83.30213,83.59827,83.8944,84.190533,84.51398,84.83742,85.16086,85.4843,85.807747,86.1601,86.51246,86.86481,87.21717,87.569537,87.7581,87.94666,88.13522,88.32378,88.512349,88.73572,88.95908,89.18245,89.40582,89.629183,89.72958,89.82999,89.93039,90.03079,90.131188,90.31269,90.49419,90.6757,90.8572,91.038711,91.19022,91.34172,91.49323,91.64473,91.79622,91.95766,92.1191,92.28054,92.44198,92.603427,92.72144,92.83944,92.95744,93.07545,,
Syrian Arab Republic,SYR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,48.19738,49.02177,49.846158,50.85785,51.86953,52.88121,53.8929,54.904589,56.14067,57.37675,58.61283,59.84891,61.084997,62.18358,63.28216,64.38074,65.47932,66.577901,67.5147,68.4515,69.3883,70.3251,71.261888,72.02939,72.79689,73.56439,74.33189,75.099389,75.73492,76.37045,77.00597,77.6415,78.277042,78.91642,79.5558,80.19518,80.83456,81.473943,82.014,82.55405,83.09411,83.63416,84.174213,84.63927,85.10433,85.56939,86.03445,86.499515,86.55947,86.61942,86.67937,86.73933,,
Tajikistan,TJK,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,60.56788,61.12756,61.687243,62.24411,62.80097,63.35783,63.91469,64.471557,64.88416,65.29675,65.70935,66.12195,66.534558,66.79729,67.06001,67.32274,67.58546,67.848189,68.16667,68.48515,68.80363,69.12212,69.440601,69.67393,69.90727,70.14061,70.37395,70.607285,70.34509,70.08289,69.82069,69.55849,69.296293,69.46278,69.62927,69.79576,69.96225,70.12873,70.49876,70.86879,71.23882,71.60886,71.978878,72.38052,72.78217,73.18381,73.58545,73.987102,74.20723,74.42735,74.64748,74.8676,,
Tanzania,TZA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,38.50979,38.87062,39.231444,39.65519,40.07895,40.5027,40.92645,41.350199,41.8675,42.38481,42.90211,43.41941,43.93672,44.57354,45.21036,45.84718,46.484,47.120828,47.33745,47.55407,47.77069,47.98732,48.203939,48.2794,48.35486,48.43032,48.50579,48.581247,47.8595,47.13774,46.41599,45.69424,44.972495,44.34841,43.72433,43.10024,42.47616,41.852076,42.16861,42.48513,42.80166,43.11819,43.434719,45.14419,46.85366,48.56313,50.27259,51.982062,53.88188,55.78169,57.68151,59.58132,,
Thailand,THA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,54.60388,55.34638,56.088884,56.50373,56.91858,57.33343,57.74828,58.163121,58.89477,59.62642,60.35806,61.08971,61.821352,62.55985,63.29835,64.03685,64.77535,65.513849,66.35735,67.20084,68.04434,68.88784,69.731343,71.14663,72.56191,73.9772,75.39248,76.807763,77.23123,77.6547,78.07817,78.50164,78.925098,78.9996,79.07411,79.14862,79.22313,79.29764,79.4207,79.54375,79.66681,79.78986,79.912927,80.44147,80.97002,81.49857,82.02712,82.555676,82.80122,83.04678,83.29233,83.53788,,
Timor-Leste,TMP,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,22.64662,23.251,23.855366,24.49396,25.13256,25.77116,26.40976,27.04835,27.7249,28.40145,29.078,29.75456,30.431109,28.37665,26.32218,24.26772,22.21326,20.158798,22.20268,24.24656,26.29044,28.33432,30.378203,32.40312,34.42803,36.45295,38.47786,40.502778,41.6403,42.77782,43.91535,45.05287,46.1904,47.97763,49.76485,51.55208,53.33931,55.12654,56.70401,58.28148,59.85895,61.43642,63.013888,63.98785,64.96182,65.93579,66.90976,67.883717,68.83585,69.78799,70.74012,71.69225,,
Togo,TGO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,33.63607,34.61052,35.584962,36.57101,37.55705,38.5431,39.52914,40.515193,41.50776,42.50032,43.49288,44.48544,45.478003,46.40641,47.33483,48.26324,49.19165,50.120066,50.99797,51.87588,52.75378,53.63169,54.509593,54.99443,55.47927,55.96412,56.44896,56.933794,56.62949,56.32518,56.02088,55.71657,55.412269,54.44173,53.47119,52.50065,51.53011,50.559573,50.54618,50.53279,50.51941,50.50602,50.492628,50.68737,50.88211,51.07685,51.27159,51.466324,52.01077,52.55521,53.09966,53.6441,,
Tonga,TON,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,57.33417,58.06441,58.794656,59.53231,60.26995,61.0076,61.74525,62.482904,63.14917,63.81543,64.48169,65.14795,65.814216,66.36851,66.9228,67.47709,68.03138,68.585682,69.13631,69.68694,70.23756,70.78819,71.338824,71.8118,72.28477,72.75775,73.23073,73.703704,73.89336,74.08302,74.27268,74.46234,74.652014,74.93175,75.21148,75.49121,75.77094,76.050664,76.52584,77.00101,77.47619,77.95136,78.426534,78.81314,79.19975,79.58636,79.97298,80.359577,80.62833,80.89709,81.16586,81.43462,,
Trinidad and Tobago,TTO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,63.62907,64.63468,65.640291,65.98667,66.33305,66.67944,67.02582,67.37221,67.78977,68.20734,68.6249,69.04247,69.460037,69.82902,70.198,70.56698,70.93596,71.304929,71.42049,71.53606,71.65163,71.7672,71.88277,71.99734,72.11192,72.2265,72.34108,72.45565,72.67412,72.89259,73.11105,73.32952,73.547982,73.86827,74.18856,74.50885,74.82914,75.149425,75.46244,75.77545,76.08846,76.40147,76.714498,76.83514,76.9558,77.07645,77.1971,77.317736,77.51482,77.71191,77.909,78.10609,,
Tunisia,TUN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,34.14,34.99174,35.843497,37.10084,38.35818,39.61552,40.87287,42.13021,43.91426,45.6983,47.48235,49.2664,51.050442,52.46427,53.8781,55.29193,56.70576,58.119588,59.92368,61.72776,63.53185,65.33595,67.140034,68.17618,69.21232,70.24846,71.2846,72.320746,73.60483,74.88892,76.173,77.45709,78.741168,79.68387,80.62656,81.56926,82.51196,83.454659,83.80579,84.15691,84.50804,84.85917,85.21028,85.4245,85.63872,85.85294,86.06715,86.281372,86.54745,86.81354,87.07962,87.3457,,
Turkey,TUR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,46.39214,47.36124,48.330347,49.23046,50.13057,51.03069,51.9308,52.830915,53.77993,54.72894,55.67795,56.62696,57.575971,58.57923,59.58249,60.58574,61.589,62.592251,63.58186,64.57147,65.56108,66.55069,67.540306,68.35521,69.17011,69.98502,70.79992,71.61484,72.38367,73.1525,73.92133,74.69016,75.459002,76.31403,77.16905,78.02408,78.8791,79.73412,80.40311,81.07211,81.7411,82.41009,83.079081,83.60996,84.14085,84.67173,85.20261,85.7335,86.11136,86.48921,86.86707,87.24492,,
Turkmenistan,TKM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,57.06177,57.69739,58.333005,58.97177,59.61053,60.24929,60.88806,61.526817,61.99132,62.45583,62.92033,63.38483,63.84934,64.13754,64.42574,64.71394,65.00214,65.290338,65.75763,66.22492,66.69221,67.15951,67.626808,67.89785,68.16889,68.43993,68.71098,68.982015,69.16774,69.35346,69.53918,69.72491,69.910628,69.93085,69.95109,69.97132,69.99155,70.011775,70.15732,70.30286,70.44841,70.59396,70.739494,70.99511,71.25072,71.50634,71.76196,72.017562,72.25468,72.49181,72.72893,72.96605,,
Turks and Caicos Islands,TCA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Tuvalu,TUV,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Uganda,UGA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,39.06023,39.83918,40.618132,41.36013,42.10212,42.84411,43.58611,44.328105,44.61055,44.893,45.17545,45.4579,45.740349,45.79743,45.85451,45.91159,45.96867,46.025751,46.05983,46.0939,46.12797,46.16204,46.196116,45.82972,45.46332,45.09692,44.73052,44.364124,42.86646,41.3688,39.87114,38.37348,36.875814,36.26416,35.6525,35.04085,34.42919,33.81754,34.94166,36.06577,37.18989,38.314,39.438123,41.16416,42.89019,44.61623,46.34227,48.068298,49.81591,51.56352,53.31113,55.05875,,
Ukraine,UKR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,77.8532,78.61343,79.373666,79.6962,80.01873,80.34126,80.6638,80.986324,81.06601,81.14569,81.22537,81.30505,81.384735,81.23455,81.08437,80.93418,80.784,80.633817,80.5779,80.52198,80.46606,80.41015,80.354228,80.62581,80.89739,81.16898,81.44056,81.712129,81.34894,80.98575,80.62256,80.25937,79.896162,79.5331,79.17004,78.80698,78.44392,78.080847,78.14796,78.21507,78.28217,78.34928,78.416399,78.45744,78.49848,78.53952,78.58056,78.621602,78.81347,79.00533,79.1972,79.38906,,
United Arab Emirates,ARE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,53.75272,55.00376,56.254801,57.45307,58.65134,59.84961,61.04787,62.246138,63.20096,64.15578,65.1106,66.06541,67.020231,67.7969,68.57357,69.35024,70.12691,70.903581,71.5397,72.17581,72.81193,73.44804,74.084173,74.60715,75.13013,75.65311,76.17609,76.699055,77.14203,77.58501,78.02798,78.47096,78.913932,79.33115,79.74838,80.16561,80.58284,81.000058,81.40454,81.80903,82.21352,82.618,83.022486,83.39162,83.76075,84.12988,84.49902,84.868133,85.12857,85.38901,85.64944,85.90988,,
United Kingdom,GBR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,80.57363,80.76141,80.949191,81.11214,81.2751,81.43806,81.60101,81.763968,81.84827,81.93258,82.01688,82.10119,82.185509,82.33846,82.4914,82.64435,82.79729,82.950227,83.22367,83.49712,83.77056,84.04401,84.317461,84.54884,84.78023,85.01161,85.243,85.474372,85.79382,86.11327,86.43272,86.75217,87.071627,87.31114,87.55066,87.79018,88.02969,88.269212,88.4762,88.6832,88.89019,89.09718,89.304177,89.48006,89.65594,89.83182,90.0077,90.18358,90.31973,90.45587,90.59202,90.72816,,
United States,USA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.24574,78.39785,78.549972,78.6785,78.80702,78.93555,79.06407,79.192601,79.42991,79.66721,79.90452,80.14182,80.379121,80.83505,81.29099,81.74692,82.20285,82.658767,82.91228,83.16581,83.41933,83.67286,83.926373,84.05558,84.18479,84.314,84.44321,84.572418,84.73653,84.90063,85.06474,85.22885,85.392943,85.5332,85.67346,85.81372,85.95398,86.094232,86.2182,86.34217,86.46614,86.59011,86.714081,86.86683,87.01958,87.17233,87.32507,87.477839,87.60961,87.74139,87.87316,88.00494,,
Upper middle income,UMC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,44.901325842065496,45.514930206373904,46.051539127232104,48.779116565533506,51.5134490387142,54.2445548989447,56.97014543917871,59.7041270445309,61.0815947959338,62.460346696128504,63.842217081707204,65.2254938588334,66.60669867590009,67.1838729510075,67.7621794578665,68.3414514199511,68.9219872481345,69.5039725382294,70.1008465318702,70.7004719274418,71.3024159214702,71.9072716061423,72.5150215939936,73.0314008879965,73.54794258490091,74.0654603994855,74.58477175467159,75.10640449102891,75.4977358870024,75.8897980553467,76.2830475679842,76.6774439099059,77.0729630095512,77.3847937454248,77.69650971629109,78.0079335018559,78.3187764959026,78.6293484166083,79.0505064016395,79.4693740987743,79.8869470033634,80.307911343091,80.73603921212201,81.0684184090227,81.4011390056393,81.732776986935,82.0624066445796,82.3902691020151,82.7448109209572,83.09764780466479,83.447907614893,83.7984142057054,,
Uruguay,URY,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.22877,76.6322,77.035631,77.1285,77.22137,77.31425,77.40712,77.499984,77.59153,77.68308,77.77464,77.86619,77.957732,78.27079,78.58385,78.89692,79.20998,79.523038,79.89208,80.26113,80.63018,80.99923,81.368268,81.64159,81.91492,82.18826,82.46159,82.734911,82.94712,83.15933,83.37154,83.58376,83.795977,84.02377,84.25156,84.47935,84.70714,84.93493,85.20161,85.4683,85.73499,86.00167,86.268345,86.50409,86.73983,86.97557,87.21131,87.447055,87.56409,87.68112,87.79816,87.91519,,
Uzbekistan,UZB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,64.90485,65.5036,66.102352,66.69872,67.29509,67.89146,68.48782,69.084191,69.51139,69.93859,70.36579,70.79299,71.220181,71.51431,71.80843,72.10255,72.39667,72.690788,73.14014,73.58949,74.03883,74.48818,74.937524,75.17204,75.40656,75.64108,75.8756,76.110105,75.51039,74.91068,74.31096,73.71124,73.11154,73.20972,73.3079,73.40608,73.50426,73.602435,73.72258,73.84273,73.96288,74.08302,74.203165,74.30679,74.41042,74.51405,74.61768,74.721297,74.92595,75.1306,75.33525,75.5399,,
Vanuatu,VUT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,40.90643,41.76189,42.61735,43.4687,44.32005,45.1714,46.02275,46.874096,47.79991,48.72572,49.65153,50.57734,51.503149,52.45366,53.40416,54.35466,55.30517,56.255679,57.23251,58.20935,59.18618,60.16301,61.139851,61.70428,62.26871,62.83314,63.39757,63.962009,64.69397,65.42593,66.15788,66.88984,67.621799,68.41168,69.20156,69.99144,70.78132,71.5712,72.2878,73.0044,73.721,74.4376,75.154209,75.7619,76.3696,76.97729,77.58499,78.192679,78.71823,79.24378,79.76933,80.29488,,
"Venezuela, RB",VEN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,57.83899,58.91336,59.98772,61.14571,62.3037,63.46169,64.61967,65.777667,66.76839,67.75911,68.74983,69.74055,70.731274,71.5037,72.27613,73.04856,73.82099,74.593414,75.05528,75.51715,75.97902,76.44089,76.902764,77.31578,77.7288,78.14182,78.55483,78.967865,79.22095,79.47404,79.72713,79.98022,80.233317,80.4454,80.65748,80.86956,81.08164,81.293717,81.47034,81.64696,81.82358,82.0002,82.176831,82.44,82.70317,82.96634,83.22951,83.492685,83.67915,83.86562,84.05209,84.23856,,
Vietnam,VNM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,65.68392,66.78677,67.889625,68.51517,69.14072,69.76627,70.39182,71.017364,69.99783,68.97829,67.95875,66.93921,65.919684,68.09772,70.27577,72.45382,74.63187,76.809907,77.28623,77.76256,78.23888,78.71521,79.191528,79.58435,79.97717,80.37,80.76282,81.155652,81.54445,81.93325,82.32205,82.71085,83.099649,83.46215,83.82465,84.18714,84.54964,84.912142,85.19473,85.47733,85.75992,86.04251,86.325099,86.46949,86.61388,86.75826,86.90265,87.047047,87.14212,87.23719,87.33226,87.42733,,
Virgin Islands (U.S.),VIR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,64.89917,65.77632,66.653458,67.54071,68.42796,69.31522,70.20247,71.089735,72.00109,72.91245,73.8238,74.73515,75.646521,76.36079,77.07507,77.78934,78.50361,79.217876,79.71944,80.22102,80.72259,81.22416,81.725723,82.37279,83.01985,83.66692,84.31398,84.96104,85.39447,85.8279,86.26134,86.69477,87.128206,87.38499,87.64177,87.89855,88.15533,88.412112,88.55928,88.70644,88.85361,89.00077,89.14794,89.30318,89.45841,89.61365,89.76888,89.924132,90.1041,90.28406,90.46402,90.64398,,
West Bank and Gaza,WBG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,46.01708,46.69604,47.375,48.3374,49.2998,50.2622,51.22459,52.187,53.18684,54.18668,55.18652,56.18636,57.1862,58.2794,59.3726,60.4658,61.559,62.6522,63.71758,64.78296,65.84834,66.91371,67.9791,68.85854,69.73798,70.61742,71.49686,72.3763,72.9552,73.5341,74.11301,74.69191,75.2708,75.81136,76.35192,76.89248,77.43304,77.9736,78.30782,78.64204,78.97626,79.31049,79.6447,79.9486,80.2525,80.5564,80.86031,81.1642,81.51469,81.86517,82.21566,82.56615,,
World,WLD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,52.6869130394071,53.356402044022204,53.967270050860904,55.2332234874817,56.5071204782981,57.7769145342283,59.033833552552004,60.297254418444794,61.0465045972678,61.81246467354771,62.576428155757796,63.3504552704649,64.1289366264859,64.6991307990854,65.2795892296528,65.8614724907598,66.4409062900195,67.0277902858171,67.4822790506887,67.9431739099869,68.4080551704455,68.8791538230449,69.3551139117316,69.7407148291994,70.1230528364314,70.5029997540298,70.8818160828228,71.2589785647463,71.5164642642539,71.7737175009141,72.0311228924638,72.28801483105109,72.5412612866292,72.7644147450877,72.9884393583933,73.2198283835578,73.4526417983566,73.6910821774795,74.02078946205621,74.35381892673809,74.68955270857809,75.0289132081343,75.37430731497841,75.7551192847618,76.13732987798109,76.518737891398,76.899311131718,77.2794304951358,77.60762757475621,77.9305071864417,78.24809484598991,78.5639101625034,,
"Yemen, Rep.",YEM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,24.66352,25.76998,26.876433,27.98336,29.0903,30.19723,31.30416,32.411092,33.49448,34.57787,35.66126,36.74465,37.828038,39.13853,40.44902,41.75952,43.07001,44.380505,45.76365,47.1468,48.52995,49.9131,51.296253,52.35412,53.41198,54.46985,55.52771,56.585588,57.08725,57.58891,58.09056,58.59222,59.093887,59.44788,59.80187,60.15586,60.50986,60.863844,61.1582,61.45256,61.74691,62.04127,62.335627,62.59278,62.84995,63.10711,63.36427,63.621421,63.94518,64.26893,64.59268,64.91644,,
Zambia,ZMB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,40.39577,40.92781,41.459855,41.95802,42.45618,42.95435,43.45251,43.95068,44.62196,45.29323,45.96451,46.63578,47.307066,47.66141,48.01576,48.37011,48.72445,49.078801,48.49754,47.91627,47.33501,46.75374,46.172481,44.27952,42.38655,40.49359,38.60063,36.707672,34.77188,32.8361,30.90031,28.96452,27.028731,26.28528,25.54184,24.79839,24.05494,23.311493,24.01056,24.70963,25.4087,26.10777,26.806835,29.7243,32.64177,35.55924,38.47671,41.394182,44.56546,47.73674,50.90801,54.07929,,
Zimbabwe,ZWE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,49.47774,50.01902,50.560305,51.05333,51.54635,52.03938,52.5324,53.025424,53.52543,54.02543,54.52544,55.02544,55.525451,56.15412,56.78278,57.41145,58.04012,58.668787,59.56274,60.4567,61.35065,62.24461,63.13856,63.16753,63.1965,63.22548,63.25445,63.283415,61.01192,58.74044,56.46895,54.19746,51.925969,48.10853,44.29108,40.47364,36.6562,32.838756,30.9528,29.06683,27.18087,25.29491,23.408948,24.53848,25.66802,26.79756,27.92709,29.056628,34.28754,39.51845,44.74936,49.98027,,
